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Abstract
In this study I investigated the mechanisms of clustering of the apoptosis receptor CD95
after induction with its ligand and the oligomerization level before induction. Previous
studies demonstrated that receptor clustering is an essential part in apoptosis signaling.
Mostly using biochemical methods and nuclear magnetic resonance the essential role of
various mechanisms in receptor clustering could be shown, such as lipid raft localization of
the receptor, clustering via the receptor death domain and internalization. An oligomer-
ization of receptors before induction via a so called pre-ligand assembly domain could be
shown at high concentrations, so that typically the receptor is assumed to be trimeric
before induction. Moreover a consistent model of the role of all mechanisms in diﬀerent
cell types and direct observation on the plasma membrane is still missing. Therefore
I investigated receptor clustering in single living cells on the cell membrane using mi-
croscopy. In particular I quantified intensities to correlate with the number of molecules.
and studied receptor clustering by dynamics measurements using fluorescence recovery
after photobleaching. I observed that receptor clustering is concentration dependent and
in HeLa at high receptor concentrations the ligand as only crosslinking mechanism yields
mean clusters size of seven molecules. Death domain assembly and lipid raft localization
do not eﬀect clustering in this cell type. At physiological expression levels the pre-ligand
assembly shows an oligomer distribution with an eminent part of monomers or dimers.
By knockdown of the receptor the distribution can be pushed to monomers. I made a
consistent study for the type II cell line HeLa, considering many proposed clustering
mechanisms and showed that ligand binding alone is a strong mechanism that can lead
to high levels of clustering. I propose a model where the receptor is present as monomers
or dimers at physiological concentrations in the absence of induction.
Kurzfassung
In dieser Arbeit habe ich den Clusterungs-Mechanismus des CD95 Rezeptors nach Lig-
andinduktion und der Oligomerisationsstatus vor Induktion untersucht. Bisherige Stu-
dien zeigten, dass Clustern von Rezeptoren einen wesentlichen Teil im Apoptose-Signalweg
darstellt. Mit hauptsachlich biochemischen Methoden und Kernspinresonanz wurde der
Einfluss von verschiedenen Mechanismen auf ein Clustern des Rezeptors erforscht, ins-
besondere eine Anordnung des Rezeptors in Lipid Rafts, Internalisierung und Bindung
über eine Domäne des Rezeptors namens ”death domain”. Ebenfalls biochemische Meth-
oden konnten eine Bindung zwischen Rezeptoren vor Induktion über die so genannte
Pre-Ligand-Assembly-Domäne (PLAD) aufdecken, so dass momentan das Modell eines
Rezeptortrimers weit verbreitet ist. Zudem fehlt ein einheitliches Model zur Beschrei-
bung aller Cluster-Mechanismen in unterschiedlichen Zellen ebenso wie Messungen direkt
auf der Zellmembran. Daher habe ich das Rezeptor-Clustern auf der Zellmembran von
lebenden Zellen mit Mikroskopiemethoden untersucht. Insbesondere wurden Intensitäten
quantifiziert um Molekülanzahlen pro Cluster zu ermitteln desweiteren wurden Aggrega-
tion mit Diﬀusionsbestimmung mit Bleichexperimenten gemessen. Ich habe festgestellt,
dass das Clustern von Rezeptors von der Rezeptorkonzentration abhängt. In HeLa-Zellen
führt die Vernetzung durch den Liganden, als alleiniger Mechanismus zu Clustergrößen
von sieben Molekülen. Die Verbindung der death domains und Lipid Raft Lokalisierung
wurden als Aggregationsmechanismen in diesem Zelltyp ausgeschlossen. Bei physiologis-
chen Rezeptorkonzentrationen vor Induktion folgt der Rezeptor einer Anzahlverteilung
mit einem erheblichen Anteil an Monomeren oder Dimeren. In Zellen mit künstlich ver-
ringerter Rezeptorexpression konnte die Verteilung hin zu Monomeren verschoben wer-
den. Ich habe eine einheitliche Untersuchung der HeLa Zelllinie des Types II angestellt
unter Betrachtung aller vorgeschlagenen Cluster-Mechanismen und habe gezeigt, dass
Ligandeninduktion als einziger Mechanismus zu großen Rezeptoraggregationen führen
kann. Für physiologische Konzentrationen ohne Induktion ist das Modell eines Rezep-
tors anzu-nehmen, der hauptsächlich mono- und dimerisch vorliegt.
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1. Apoptosis and CD95-Receptor Clustering
1.1. Apoptosis
Apoptosis is one mode of programmed cell death in multicellular organisms, designed for
the removal of unwanted cells of the same body.
Contrary to necrosis - a premature demise of single cells of an organism accompanied
by inflammation - apoptosis is an organized active process of the dying cell. Following
a biochemical cascade the cell degrades itself, so that its remains can be phagocytosed
by the surrounding cells and components can be recycled. In that process the apoptotic
cells show typical morphological features, notably blebbing, cell shrinkage, nuclear frag-
mentation and chromatin degradation [1], instead of bursting and spilling any possibly
damaging content. In a human body 50 to 70 billion cells die every day due to apoptosis
thus maintaining the functionality of the organism.
1.1.1. The Functions of Apoptosis
Apoptosis’ central task of killing unwanted cells leads to several diﬀerent areas where
this process plays a central role.
Typically apoptosis eliminates abnormal, misplaced, non-functional or harmful cells, Fig-
ure 1.1 F. Using cytotoxic T cells and natural killer cell to eliminate infected cells in time
is crucial to prevent viral infections from spreading. Another example is apoptosis as
response to stress or DNA damage, e.g. by UV-light.
A second task of apoptosis is the maintenance of homeostasis, Figure 1.1 E. In healthy
bodies blood and skin cells, for instance, are constantly renewed. This proliferation,
however, has to be continuously compensated by cell death.
Apoptosis plays a major role in the development of most plants and metazoan organisms
especially for tissue remodeling, such as sculpting and deleting structures, Figure 1.1 A,
B, C, D. The formation of digits in some higher vertebrates is a well-studied example,
where apoptosis eliminates the cells between developing digits .
Apoptosis is also indispensable in the development of the immune system, especially in
the maturation of lymphocytes. About 95% of the freshly produced T-cells are deleted
in the thymus during maturation, because they are either not functional, failed to rear-
range their T cell receptor gene, or even autoreactive [3]. The termination of an immune
response also requires the elimination of the activated mature T cells by apoptosis.
1.1.2. Apoptosis Malfunctioning and Related Diseases
Since apoptosis is implicated in a plethora of vital functions of a healthy organism,
malfunctioning of apoptosis can lead to an extensive variety of diseases. These can be
10
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Cell
350
Figure 2. Some Functions of PCD in Animal
Development
(A and B) Sculpting.
(C and D) Deleting unwanted structures.
(E) Controlling cell numbers.
(F and G) Eliminating nonfunctional, harmful,
abnormal, or misplaced cells.
form functioning kidneys in fish and amphibian larvae, PCD also functions as part of a quality-control pro-
cess in animal development, eliminating cells that arebut they are not used in mammals and are eliminated
by PCD. Subplate neurons are required transiently dur- abnormal, misplaced, nonfunctional, or potentially dan-
gerous to the organism. Striking examples are seen ining the development of the mammalian cerebral cortex
and are subsequently removed by PCD. The Mu¨llerian the vertebrate immune system, where developing T and
B lymphocytes that either fail to produce potentiallyduct forms the uterus and oviducts in female mammals,
but it is not needed in males and is thought to be lost useful antigen-specific receptors or produce self-reac-
tive receptors that make the cells potentially dangerousby PCD. Conversely, the Wolffian duct forms the vas
deferens, epididymis, and seminal vesicle in males, but are eliminated by PCD (Figure 2F). Animal cells have
poorly understood ways of recognizing when they areit is not needed in females and is eliminated by PCD
(Figure 2D). damaged and will undergo PCD if the damage is great
enough (Figure 2G). If DNA is damaged sufficiently in aIn many organs, cells are overproduced and then
culled by PCD to adjust their numbers (Figure 2E). In mammalian cell, for example, the cell can activate its
death program by various mechanisms, one of whichthe vertebrate nervous system, for example, both neu-
rons and oligodendrocytes are generated in excess, and depends on the p53 tumor-suppressor protein (Clarke
et al., 1993; Lowe et al., 1993). This response not onlyup to half or more are eliminated by PCD, apparently to
match their numbers to the number of target cells they serves as an anticancer mechanism, but also seems to
help prevent the birth of defective offspring. If pregnantinnervate (Barde, 1989;Oppenheim, 1991) or thenumber
of axons they myelinate (Barres et al., 1992), respec- mice are irradiated, the number of offspring produced
decreases, as many of the irradiated embryos die, buttively. Although the influence of cell proliferation in con-
trolling cell numbers in animal development has re- there is surprisingly little increase in the occurrence of
birth defects among those mice that are born. Mouseceived more attention than the influence of PCD, PCD
can be the dominant mechanism. In well-fed hydra, for embryos lacking both copies of the p53 gene, however,
tend not to die, and many are instead born with abnor-example, cell proliferation greatly outstrips cell death,
and new hydra continually bud off from the parent ani- malities (Norimura et al., 1996).
Thedeath programmay be involved in producing spe-mal; when hydra are starved, growth stops, mainly be-
cause cell death greatly increases, while the rate of cell cialized differentiated cells without organelles. Certain
cell types, including skin keratinocytes, lens epithelialproliferation changesvery little (Bosch andDavid, 1984).
Figure 1.1.: The diﬀerent functions of apoptosis in animal developement according to [2]
categorized into two groups, depending on whether excessive or too little apoptosis oc-
curs [4], [5].
Unwanted apoptosis leads to a pathological cell loss, as it occurs with ischemic diseases,
Alzheimer’s disease, neurodege erative disorders or AIDS [6]. W en apoptosis is insuf-
ficient cells can grow exc ssively leading e.g. to tumor growth or aut immune diseases [7].
1.1.3. The Process f Apoptosis and its Molecular M chan sm
It would be very harmful for the organism, if half-dead cells were around, therefore the
decision for apoptosis should be taken i an all or nothing manner. The need for apo to-
sis can come from the cell itself, from its sur ounding issue or from a cell hat is part of
the immune system. Therefore there are various stimuli, extrinsic or intrinsic inducers,
that induce the apopt tic sign ling. This signaling pathway then leads to the decision,
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whether to start apoptosis or instead block the apoptotic signal and lead to a pro-survival
pathway.
Apoptotic cell death is carried out by a group of proteases called caspases. There are
initiator caspases, namely caspase 8, 10, 9 and 2) that upon signaling activate the eﬀec-
tor caspases (caspase 3, 7 and 6) by proteolytic cleavage, the so called caspase cascade.
The eﬀector caspases then cleave the proteins of the cell. Those proteins include the
cytoskeleton proteins, leading to a shrinkage of the cell and a breakdown of the nuclear
envelope. Further they activate the endonucleases, that are responsable for the DNA
degradation into chromatin bodies, with DNA fragments of 180-185 base pairs length.
The cell membrane shows irregular buds, a process called blebbing, and the cell breaks
apart into vesicles, the so called apoptotic bodies, that are later phagocytosed by other
cells.
In a normal living cells, when no apoptosis signal is present, the caspase inhibitor XIAP
(X-chromosome linked inhibitor of apoptosis protein) is responsible for inhibiting wrongly
activated eﬀector caspases and enzymatically targeting them for degradation. When
apoptosis in signaled, the equilibrium between XIAP and the caspases is shifted to allow
for the caspase cascade to execute apoptosis. There are two signaling pathways that can
lead to this shift of equilibrium - the extrinsic and the intrinsic pathway.
The main feature of the evolutionary older intrinsic pathway is the permeabilization of
the mitochondria outer membrane (MOMP), that leads to release of cytochrome c and
other pro-apototic factors such as SMAC (small mitochondria-derived activator of cas-
pases). SMAC inhibits XIAP thus shifting the equilibrium. Cytochrome C binds to
apoptotic protease activating factor-1 (Apaf-1). This interaction with cytochrome c in-
duces a conformational change in Apaf-1, promoting Apaf-1 oligomerization to initiate
apoptosome formation. The apoptosome then binds to the pro-caspase 9 to start the
caspase cascade and execute apoptosis. The intrinsic pathway can be started by various
stimuli and is regulated by various proteins, such as those of the Bcl-2 family, that can
promote and inhibit apoptosis via this pathway.
One way to start apoptosis is the induction of death receptors of the so called TNF
receptor family. This family of receptors has a common motive in the intracellular part,
called the death domain [9]. This death domain can oligomerize and recruit adaptor
proteins TRADD or FADD [10]. These in turn can directly recruit initiator caspases and
by dimerization these are activated [11].
The extrinsic pathway is induced by receptors of the so called TNF receptor family, called
death receptors. This family of receptors has a common motive in the intracellular part,
called the death domain [9]. This death domain can oligomerize and recruit adaptor
proteins TRADD or FADD [10]. These in turn can directly recruit initiator caspases and
12
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Figure 1.2.: Model of the intrinsic and extrinsic signaling pathways for apoptosis. The intrinsic
apoptosis pathway is characterize by mitochondria regulation. The extrinsic path-
way is induced by death receptor induction and can induce apoptosis by directly
activating the caspase cascade [8]
by dimerization these are activated [11]. When this signal is strong enough to overcome
the caspase inhibitor XIAP the necessary caspase cascade can directly start apoptosis as
described above.
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1.2. The CD95 Receptor
CD95-mediated Functions of Apoptosis
One way to initialize apoptosis is the induction of the CD95 receptor, one of the so-called
death receptors. This particular pathway plays an eminent role in the immune system
[12]:
CD95 is responsable for the peripheral deletion of activated mature T cells at the end
of an immune response, called T cell homeastasis, the killing of targets such as virus-
infected cells or cancer cells by cytotoxic T cells or natural killer cells, the removal of
autoreactive T cells [13], [3] and the killing of inflammatory cells at immune-privileged
sites such as the eye and testis [14], [15].
1.2.1. The Structure of CD95
CD95 (Tumor necrosis factor receptor superfamily member 6, APO-1, APT-1) is a trans-
membrane receptor of the TNF-receptor superfamily, which has a predominant function
in apoptosis. It is a type I transmembrane protein with a mass of 45 kDa.
N C 
extra intra trans 
CRDs PLAD Palm site DD 
Figure 1.3.: Structure of CD95. The N-termininal extracellular domain contains three cysteine
rich domains and the so called pre ligand assembly domain (PLAD). On the in-
tracellular part contains the characteristic death domain. The amino acid cysteine
199 serves as a palmitoylation site that is located on the intracellular part of the
receptor near the transmembrane domain.
The structure is very similar to many TNF receptors, Figure 1.3. As a transmembrane
receptor it has the typical hydrophobic transmembrane helix (amino acids 174-190) and
an extracellular and an intracellular domain.
The intracellular part contains the death domain (DD), an 80 amino acid long domain
characteristic for all TNF receptors. This key domain of these receptors binds one of the
adaptor proteins FADD or TRADD to serve as a platform for the caspase activation,
that will lead to apoptosis.
Another homologous part to all TNF receptors are the three highly conserved cystein-
rich-domains (CRD) located in the extracellular part (CRD1: 47-83, CRD2: 84-127,
CRD3-128-166). Contrary to most other TNFs the linker between CRDs and transmem-
14
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brane domains is only 8 amino acids short allowing for less flexibility. CRD2 and CRD3
[9] are responsable for ligand binding, while the functional role of CRD1 remained ob-
scure for a long time.
In 1999, however, the pre-ligand-assembly domain (PLAD) was identified in CD95 and
also other members of the TNF receptor superfamily [16], ([7] in CD95), ([17] in the re-
ceptors p60 and p80 of the TNFR superfamily). It is part of the CRD1 at the N-terminal
end of the receptor and it mediates a specific ligand-independent assembly of the recep-
tors. The receptors were shown to self associate via these domains by various biochemical
and biophysical techniques [9]: gel filtration and chemical crosslinking experiments [7]
or fluorescence energy transfer (FRET) [18]. With the latter it could be shown that
dominant interference of CD95 mutant of the disease autoimmune lymphoproliferative
syndrome ( ALPS), where the death domain is either mutated of truncated, is occurring
through pre-ligand association of receptors via the PLAD-domain.
1.2.2. The CD95 Signaling Pathway
Apoptosis can be initiated by CD95. Upon induction of apoptosis the adaptor molecule
FADD (Fas-associated-protein with DD) binds homotypically to the death domain of
CD95 receptor [12], [19]. FADD then recruits procase 8 or 10 via its death eﬀector
domain to form a complex called DISC (death inducing signaling complex) thereby con-
necting the receptor to the apoptotic eﬀector machinery [12]. Procaspase 8 is activated
by dimerization at the DISC [20], auto-cleavage then leads to further stabilization and
possible release to the cytosol. Caspase 8 is an initiator caspase that - depending on cell
type - can induce the intrinsic or extrinsic apoptosis signaling pathway.
Induction Mechanisms
Given its importance for the protection against harmful processes, CD95-mediated apop-
tosis can be initialized in various diﬀerent mechanisms.
It was shown that the CD95 receptor can mediate apoptosis by chemical activation as in
the case of apoptosis by ET-18-OCH3 [21], [22]
More commonly CD95 activation happens through induction of the receptor by binding
of the respective ligand or antibody: The natural CD95-ligand presents itself in two dif-
ferent form. The transmembrane form is presented on the plasma membrane of another
cell, such as a natural killer cell. (Referenz). The soluble form is generated by cleavage of
the transmembrane form, it will furthermore referred to as soluble CD95 ligand, sCD95L
(Referenz).
15
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Experimentally CD95 can by activated by artificial inducers. For instance ILZ-sCD95L
is an artificial fusion of the soluble ligand to isoleuzin (ILZ) forcing a stable trimerization
of the ligand. This results in higher activation and cell death upon induction .In our
Laboratory Clarisse Liesche could show, that while sCD95L is not able to kill HeLa cells,
ILZ-sCD95L can induce 100% cell death. HeLa cells overexpressing CD95 however, are
as susceptible to the soluble form as to the ILZ and cell death occurs at same speed.
Among other artifical inducers is the use of antibodies, for instance the agonistic APO1-
3, that induces cell death as eﬃciently as the ligand. On the other hand, the antibody
APO1-1 is not agonistic, while still showing high binding aﬃnity to the receptor.
Inhibition of CD95-induced Apoptosis
In some experiments when examining the early events of apoptotic signaling and the
receptor distribution on the plasma membrane, the cells should stay intact and not die
of apoptosis. There are various ways to inhibit apoptosis.
The most direct way to inhibit apoptosis is to block the caspase cascade. The drug z-vad
irreversibly binds to the catalytic site of caspase proteases and thereby inhibits induction
of apoptosis.
From a family of proteins from herpesviruses come v-FLIPs, which contain death eﬀector
domains and can inhibit apoptosis [23] to evade host defenses and contribute to the
propagation of the virus. The human homologue is the protein c-FLIP (FLICE inhibitory
protein). It can compete with caspase 8 at the DISC and therefore inhibit caspase
activation [24], [25]. Constitutive expression of c-FLIP can lead to Hodgekin’s desease
[23].
As described before the intrinsic apoptotic pathway is regulated by members of the Bcl-2
protein family. All mitochondrial activities can be blocked by overexpression of Bcl-2 or
Bcl-xL [26], [27].
v-FLIPs is a family of proteins form a herpesvirus, that contain death eﬀector domains
and can inhibit apoptosis [23] to evade host defenses and contribute to the propagation
of the virus.
Survival Pathways
It has been shown that caspase 8 can activate the NF-κB pathway [28] and that TNF
receptors are massively involved in NF-κB survival pathways [29]. CD95 was also shown
in vivo to be involved in survival signaling in mice controlling neuronal branching in the
developing brain [30], [31] and survival signaling via the DISC could be also shown [32].
16
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1.2.3. The Two diﬀerent Cell Types
From the activation of caspase 8 there are two signaling pathways that lead to apoptosis
[33]. Cells can be divided into two types, depending on which pathway they chose. Type
I cells use the extrinsic pathway, where the caspase cascade is mainly activated directly
by the DISC, whereas type II cells choose an intrinsic pathway, where caspases are ac-
tivated via mitochondrial outer membrane permeabilization, as described above, Figure
1.2.
To test whether cells are of type I or type II, apoptosis is manipulated with Bcl-2 or
Bcl-xL. In type II cells these proteins inhibit apoptosis, while type I cells, still dye using
the extrinsic pathway, possibly slower, since they are deprived of help of the intrinsic
pathway.
For CD95-induced cell death the discriminator between type I and type II apoptosis is
the XIAP levels [34].
One example for a mixed cell type is the MCF7 lymphocyte cell line, that can be turned
from one type to the other by expression of specific proteins [33].
It has been proposed that evolution initially developed only the intrinsic pathway Scaf-
fidi1998 and extrinsic pathway was developed later.
The first signaling events on the extrinsic pathway for type I cells are very well described
in [35]. Upon induction of the ligand CD95 forms microaggregates, that can by observed
on SDS-Page-Gels [36]. Then FADD is recruited to the DISC and and CD95 forms clus-
ters that can be observed in confocal microscopy [37], a process, that can only eﬃciently
occur, with caspase 8 binding. In a next step the activated receptor is internalized into
endosomes, in an actin cytoskeleton dependent manner [38], [35].
1.2.4. Modifications of CD95
Apoptosis signaling is regulated on many diﬀerent levels, the early signaling events being
determined by the receptor and its surrounding. I want to start with modifications and
mutations on the receptor itself leading then to the further regulation mechanisms in the
surroundings, chapter 1.3 .
Ubiquitination of receptors in general is mainly responsable for surface receptor inter-
nalization, DNA repair and protein kinase activation. While ubiquitination plays a
major role in regulation and sorting of the membrane bound form of CD95L, CD95
is not massively regulated by ubiquitination. Downstream again, caspase 8 can be
further stabilized by ubiquitination and also the IAP (inhibitor of apoptosis) family
members can be regulated by ubiquitination [39].
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pathway cell line cell type
type I
SKW 6.4 lyphoblastoid
H9 T cell line
Hep G2, BJAB, L929, K50 -
MCF7 with CD95 and casp3 over-
expression
Hek 293T -
type II
CEM T cell line
Jurkat T cell line
HeLa cervical cancer (epithelial)
MCF7 breast cancer
Table 1.1.: list of cell types and their CD95 signalling pathway: according to [33]
Palmitoylation can influence membrane binding and targeting and for many receptors is
particularly responsible for localization and and enrichment in the lipid rafts, reg-
ulation eﬀective signal transduction [40]. For the vast majority of proteins palmi-
toylation is occuring post translationally at cysteine residues.
Many TNF receptors are S-palmitoylated at an intracellular membrane proximal
cysteine, e.g. death receptor 6 [41]. Also CD95 is palmitoylated at this site, cysteine
199. This palmitoylation is required for the redistribution into lipid rafts, for a raft
dependent cytoskeleton association and consecutive eﬃcient cell death in Hek293T
cells [42]. The same palmitoylation of cysteine 199 has been shown to be a pre-
requisit for the formation of SDS-stable aggregates of CD95 the B-lymphoblastoid
cell line SKW6.4 [38] (that can be found inside and outside the detergent resistant
membranes). Cysteine 199 mutants no longer form SDS-stable aggregates [38].
In death receptor 6 it was shown that palmitoylation did not play an essential role in
lipid raft targeting [41], therefore other targeting mechanisms such as extracellular
glycosphingolipid binding motifs were proposed.
Glycosylation can aﬀect the folding, traﬃcking , localization and function in the recep-
tors of the TNFR family [41]. E.g. glycosylation of death receptor 6 is required for
the localization to the plasma membrane. Eﬀects on lipid raft targeting and ligand
binding remain unresolved [41]. CD95 receptor can be glycosylated at sites N136
and N118, however this does not play a major role in DISC formation and signal
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transduction, neither in the formation of CD95 high molecular weight structures
[43].
One observation is the formation of SDS- and β-mercapto-ethanol stable aggregates of
high molecular weight after induction [36] (after crosslinking with antibody in HuT78
cells), [7], [44]. These microaggregates in SKW 6.4 cells are found both inside and outside
of detergent-resistant membranes.
1.3. Regulation Mechanisms
The decision between life and death is fatal and therefore regulation of apoptosis is mul-
tifaceted and has several independent influences [45].
In 2002 the early signaling events of CD95 in type I cells were described in detail [35]:
these are formation of microaggretates, actin-dependent FADD recruitment and later
receptor internalization. In a further study on type I cells (SKW 6.4 and H9) the same
steps were observed, and especially the mechanism of palmitoylation was further iluci-
dated with biochemical techniques, connecting the events to lipid raft localization and
caspase 8 activation [38].
These examples in particular cell types show the importance of mechanisms as lipid
raft localization, actin cytoskeleton dependence, internalization and clustering for the
regulation of CD95-mediated apoptosis.
1.3.1. The Role of Lipid Rafts in Type I and Type II cells
Lipid rafts and detergent resistant domains can be defined according to diﬀerent meth-
ods, so that statements of findings need to be done cautiously.
Muppidi and Siegel [46] showed that redistribution of CD95 into lipid rafts is an im-
portant mechanism to mediate clonotypic cell death of activated T cells. Using density
gradient fractionation it was shown that in type I cells CD95 relocalization into lipid
rafts makes the cells sensitive to CD95-mediated apoptosis. In type II cells apoptosis
appears to be independent of lipid rafts.
Gajate and Mollinedo [21], [22] showed that the ether lipid (Et-18-OCH3) induces the
redistribution of Fas into the detergent resistant domains, again determined by sucrose
gradient, which represents a self-suﬃcient step mediating a CD95-dependent apoptotic
signal.
Legembre [47] used the membrane fractions of sucrose gradient ultracentrifugation (Tri-
ton X-100 cell lysate) to define raft and non-raft localization of the CD95 receptor. They
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could show an amplification of CD95-mediated apoptosis in type II cells, that was caused
by a recruitment of the receptor to the lipid rafts. The enhancement appears to be of
the mitochondrial apoptotic pathway.
One mechanistic clue supporting redistribution of CD95 into lipid rafts is the palmitoyla-
tion of the cysteine 199 near the transmembrane region. It has been shown to be involved
in the redistribution of the receptor into the lipid rafts in Hek293 cells (established by
sucrose gradient studies), and seems to be a mandatory step in triggering eﬃcient cell
death signaling [42].
The formation of SDS-stable CD95 aggregates however was shown to involve palmitoy-
lation of the membrane proximal cysteine 199 in CD95 and Cysteine 199 mutants no
longer form SDS-stable aggregates [38].
In Jurkat cells ceramide depending capping, i.e. accumulation of the receptor in one
large domain at the plasma membrane and subsequent apoptosis could be shown. This
was abrogated by disruption of lipid rafts by cholesterol depletion with the disolvant
β-cyclodextrin [48], [49]. However the role of ceramide increase as an activator or just as
a response to CD95 activation is still not clear [3].
When inducing CD95-mediated apoptosis in Jurkat with the drug Aplidin, CD95 and
many other apoptosis signaling molecules are recruited to lipid rafts (sucrose gradient
ultracentrifugation of Triton X-100 cell lysate) [49]. This recruitment is crucial for the
capping and subsequent apoptosis.
1.3.2. The Actin Cytoskeleton
The actin cytoskeleton can play two diﬀerent roles in Apoptosis: inducing apoptosis or
mediating apoptosis.
On one hand disruption of the actin cytoskeleton is a severe injury to the cell and thus
can itself induced apoptosis [?]. This apoptosis involves CD95 and the eﬀect is reduced
in cells lacking CD95.
On the other hand studies on Jurkat, a T-cell line, observed a capping of CD95 with mi-
croscopy and enrichment of various apoptosis related proteins in lipid rafts. When actin
cytoskeleton is disrupted with cytochalasin B or with jasplakinolide no more capping and
recruitment to lipid rafts can be observed, indicating a major importance of the actin
cytoskeleton in cap formation [49].
Again in T-lymphocytes (CD4+ cells) after induction CD95 colocalizes with ezrin, a pro-
tein that links the actin cytoskeleton to the plasma membrane. Ezrin-inhibition protects
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from CD95-mediated apoptosis, showing that association to actin cytoskeleton is key
mechanism ”in rendering human T lymphocytes susceptible to the CD-mediated apop-
tosis” [50].
1.3.3. The Role of Receptor Internalization
The role of receptor internalization on signaling was studied in detail on type I cells. A
general requirement of receptor internalization for CD95-mediated cell death was shown,
where DISC components occurs only after receptor internalization in the cytosol and
inhibition of internalization impairs DISC formation and apoptosis [51].
Recent findings reveal a role for receptor internalization and endosomal traﬃcking in
selectively transmitting the signals that lead either to apoptosis or to the survival of the
cell [52].
The mechanisms lipid raft localization, actin cytoskeleton association and receptor in-
ternalization all follow the same mechanism of regulating signaling by localization in
subcellular compartments. Thereby receptor accumulation is achieved that serves sig-
naling by providing the high local caspase 8 concentrations that are needed for auto
processing of the enzyme. The role of the mechanisms can not be defined universally but
seem to be highly dependent on cell type.
1.3.4. Receptor Oligomerization on the Plasma Membrane before
Induction
There are many reasons to assume that spacial organization of CD95 on the plasma mem-
brane and its oligomerization status regulates apoptosis. It is known, that procaspase 8
upon dimerization can be auto processed to become an active caspase. This needs high
local concentrations, that can be favored by the spacial organization and clustering of
the DISC.
Often the receptor was assumed to be trimeric [53], but stringent evidence is still lacking.
There are various hypotheses and analysis with diﬀerent methods that reveal the impor-
tance of receptor organization before and after induction.
Historically for TNF receptors a so called ligand induced trimerization model was pro-
posed. The receptor before induction is monomeric on the plasma membrane and is
trimerized upon induction by a trimeric ligand. The model was supported by solution
and crystallography studies, that showed a three to three ratio of ligand and receptor [9].
In this trimeric structure the ligand chains are located between the receptor chains. By
analogy for long time CD95 was assumed to follow the ligand trimerization model.
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Pre-Ligand-Assembly
However there are reasons, that speak for a diﬀerent ordering. E.g. TNFα can bind
to both TNF-R1 and TNF-R2. A ligand induced trimerization could easily generate
hetero-receptor trimers, but only homotrimers are observed in experiments [54].
The promiscuous nature of binding of TNFα speaks for a pre-ordering of TNF receptors.
Similar considerations hold true for CD95, when studying the autoimmune diseases ALPS
(Autoimmune Lymphoproliferative Syndrome): in these diseases CD95 is mutated or
even truncated at the extracellular part. Interestingly these non-inducing receptors can
dominantly interfere with the full length CD95 and disrupt apoptosis signaling. Even
non-ligand binding receptors could interfere, speaking for a pre-ligand assembly [18] that
was shown in H9 T lymphoma cells and Hek293 T cells by fluorescence energy transfer
microscopy (FRET).
There is molecular evidence for this receptor assembly: the pre-ligand assembly domain
(PLAD) is a highly conserved domain at the extracellular end of most TNF receptors
including CD95. Using biochemical assays it was shown in Hek293T cells that the PLAD
domain is responsible for pre-association of TNF receptors [17]. For CD95 this same
function of the PLAD domain could be shown, when PLAD was deleted in the ALPS
mutations, leading to a loss of the dominant interference related to a loss of the receptor
association [18].
Is CD95 trimeric?
By analogy to TRAIL and also considering studies of a soluble form [55], CD95 ligand
assumed to be a trimer [3] and also in our laboratory Clarissa Liesche provided stringent
evidence for a trimeric structure of the ligand (data not shown).
In lack of other evidence CD95 was often assumed to be trimeric [53], [56], [3]. However
this analogy to the ligand is not stringent and directly transferrable.
[57] show on purified protein that TNF-α and TNF-β may intrinsicly be polydisperse.
The study implies, that the ”trimer formation is a dynamic process and, with decreasing
protein concentration, the trimer decays to dimers and monomers”. Crystallographic
structure analysis of TNFR-1 show, that the receptor before induction is a dimer [58]
and likewise other TNF-receptor family members CD27 and CD40 have been shown to be
dimers through intermolecular disulfide bonds [54], while crystallographic studies show
a trimer to trimer stoichiometry for TRAIL-R2 and BAFF-R3 [59] of the extracellular
receptor domain to the ligand.
It has not yet been possible to crystallize the whole CD95 receptor but only single do-
mains, thus structural findings rely on analogy to other TNF receptors, mainly TRAIL
[59] especially for receptors without induction.
The current model for receptor oligomerization assumes a pre-ligand assembly, however
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most evidence for this derives from experiments with high receptor concentrations.
1.3.5. Receptor Oligomerization after Induction
In type II cells formation of SDS-stable microaggregates and clusters visible by mi-
croscopy were observed after induction. There are various hypothesis and studies, that
investigated the role of receptor oligomerization after induction.
Another resoning that speaks for receptor oligomerization is that procaspase 8 essentially
needs to dimerize to be activated. Among other possibilities, such as chain formation
[56], the formation of hexamers or higher aggregation of the receptor and DISC gives a
simple manner to eﬀectively translate from a trimeric structure of the ligand to such a
dimeric caspase structure.
Ligand induced Trimerization
It has been shown for TNFα and LTα that the ligands form trimers [60] and upon induc-
tion form a trimeric complex with the respective receptor (Ligand induced trimerization)
[54].
The soluble form of CD95 ligand is a trimer [3], (Laboratory data by Clarissa Li-
esche).Considering structural aspects by analogy to TNFα the membrane bound form of
CD95L is considered a trimeric as well [60]. ”It seems likely, therefore, that all ligands
in this family adopt a similar tertiary structure and form oligomers” Based on this anal-
ogy it is further suggested that every CD95L-trimer binds three CD95 receptors, while
DD-interaction leads to clustering in analogy to the ligand induced trimerization of other
TNF-receptors [12].
Clustering via CD95 Death Domains or FADD
Nuclear magnetic resonance structure of the CD95 death domains [61] suggests that
CD95 is clustered via DD [61]. Two diﬀerent interaction modes for death domains (DD)
have been recently detected. The structure of a complex of CD95-DD and FADD-DD
under acidic conditions reveals a four to four stochiometry [62]. However in a more recent
study the complex showed to form an asymmetric oligomeric structure composed of 5-7
CD95-DD and 5 FADD-DD [63], ”which suggests that the CD95/FADD structure solved
under acidic conditions does not represent the physiological structure in solution” [64].
Muppidi measured self-association of the downstream molecule FADD by fluorescence
energy transfer microscopy. It was shown, that this self-association occurs via a motif
in the death eﬀector domain (DED) of the molecule and FRET in mutants lacking the
DED. Also the self association of FADD was essential for CD95-mediated apoptosis in
Jurkat cells [65].
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Using a FADD-GFP stable clone I could observe clustering of FADD upon induction in
our laboratory using total internal reflection microscopy (TIRF) kindly provided by the
Nikon Imaging Center der Universität Heidelberg, Figure 1.4.
Figure 1.4.: FADD crosslinkes after induction visible with background reduced microscopy:
HeLa stably expressing FADD-mGFP induced with ILZ-sCD95L were imaged with
total internal reflection microscopy (TIRF). This method was chosen to reduce back-
ground of the cytosolic FADD-mGFP and image only the region of the lower plasma
membrane. Time-lapse microscopy. Left: before induction. Middle: 30min after
induction. Right: 55min after induction. Scale bar: 5µm.
All these findings provide more insight on mechanisms and possible stoichiometry of
oligomerization and clustering, however evidence for oligomerization levels at physiolog-
ical conditions on the surface of living cells before and after induction is still lacking.
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1.3.6. Models of CD95 Oligomerization Mechanisms
All these regulation mechanisms can be summarized into four diﬀerent and not exclusive
models for receptor organization and the oligomerization level before and after induction:
Ligand induced receptor trimerization
This model is mainly supported by analogy to crystallographic data for TNFR-1 and
TNFβ complex. The ligand binds to exactly three oligomerization sites inside a recep-
tor trimer, therefore the stoichiometry ligand receptor is three to three and no higher
oligomers or aggregates form from the ligand receptor interaction.
Ligand induced oligomerization of pre assembled receptor
This model assumes that the receptor is not monomeric before induction, but assembled
into oligomers via a pre-ligand assembly domain. This is one way to allow for a further
oligomerization than three after induction.
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Ligand and FADD induced receptor oligomerization
This model assumes that a clustering after induction stems from self-association of the
death domains of the downstream protein FADD [10].
Translocation of induced receptors to lipid rafts
This model assumes a translocation of induced receptors to lipid rafts to be the reason
for receptor clustering after induction.
In this thesis I present my work on CD95 receptor clustering and signaling using mi-
croscopy methods to characterize receptor distribution and behavior on plasma mem-
brane based on these four not exclusive models for receptor clustering and the underlying
mechanisms.
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In this work I investigated CD95 clustering using microscopy methods. Though CD95-
mediated apoptosis signaling and accompanying mechanisms have been already studied
intensively, many questions remain open also due to a high variation of occuring mecha-
nisms depending on cell type. The receptor oligomerization level on the plasma membrane
before and after induction is not yet precisely estimated and no clear model is yet verified,
even though lots of studies indicate the importance of receptor organization for apoptosis
sensitivity. Most studies were performed in overexpression conditions using biochemical
methods and lysates or purified receptor for NMR studies. Evidence in living cells on
the plasma membrane at physiological expression levels is still rare.
The goal of this work is to characterize the receptor and its clustering in living cells,
aiming for high resolution in order to separate single receptors on the plasma membrane.
One main target was to quantify receptor amount and its oligomerization levels before and
after induction. To complement the existing knockledge, the distribution at high but also
at physiological expression in living cells was explored. A more indirect characterization
of the receptor on the plasma membrane was performed measuring its dynamics before
and after induction to conclude on clustering and its mechanisms.
2.1. Confocal Microscopy
In the year 1675 a man named Anton van Leeuwenhoek for the first time caught a glimpse
to a new world. With a microscope he studied water from a nearby pond and discovered
thousands of tiny creatures, that no one had ever seen before.
Without knowing Leeuwenhoek made way for a new age in the studies of nature. To us
may seem simple, but the germ theory itself could save thousands of lives by simple hy-
genic measures and vaccines. Still this very day microscopy is one of the most important
techniques in modern cell and molecular biology, because contrary to other techniques it
allows the observation of processes and mechanisms in living organisms.
New stains and the specific creation and use of antibodies or chemical tags, allow for a
specific staining of nearly all parts of cells and organisms. The finding of fluorescent pro-
teins e.g. the green fluorescent protein (GFP) in the 1960s and cloning in 1990s expands
massively the research possibilities. But also microscopy itself is still massively explored
and expanded: confocal microscopy enables three dimensional imaging of cells. Fast scan-
ning techniques such as spinning disc increase time resolution. Photophysical properties
of dyes allow for ph-measurement and molecular dynamics like dimerization. Bleaching
techniques can be used for diﬀusion and dynamics measurements and detailed quantifi-
cation is made possible by single molecule techniques. In the last decades high resolution
techniques such as Stimulated emission depletion (STED), 2π-microscopy, photoactivated
localization microscopy (PALM) and stochastic optical reconstruction (STORM) expand
research possibilities to the nanometer scale. A wonderful example of modern microscopy
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is the mapping of all cells during zebrafish embryogenesis and its development of the ver-
tebrate by light sheet microscopy performed by Philipp J. Keller et al. in 2008 [66].
http://www.youtube.com/watch?v=3xh441Wdv84
2.1.1. Fluorescence Microscopy
Since most microorganisms are transparent, it is necessary to increase the contrast of
single observed parts of the cells. There are device-related possibilities, such as dark field
of phase contrast, for parts with diﬀerent optical density. Most of the times however
fluorescence is used to increase contrast.
Figure 2.1.: Principle of fluorescence depicted on a Jablonski diagram: Molecules are lifted from
the ground state S0 to an excited state S1 by excitation light. Vibrations result in
little loss of energy (internal conversion). Then the molecule relaxes back to the
ground state by emitting a photon (fluorescence) of a little less energy, than the
excitation light.
Fluorescence is a photophysical property of particular molecules: These molecules have
diﬀerent energy states that can be depicted in a Jablonski diagram such as Figure 2.1.
Fluorescence occurs, when the molecule is excited to energy level S2 by absorbing light
of the energy S2 − S0, then looses some energy through vibration relaxations and then
from a lower energy level S1 relaxes to S0 by emitting a photon, with lower energy (and
higher wave length) than the exciting light.
Fluorescent molecules can eﬀectively be used to stain biological samples for microscopy.
To image one uses fluorescent microscopes, that detect only the fluorescent light: the
29
2. Microscopy Approaches to Characterize Receptors at Single Cell Level
Figure 2.2.: Setup of a fluorescent microscope: the specimen is illuminated (e.g. with laser beam)
of the excitation frequency of the observed molecules. These then emit fluorescent
light of slightly higher wave length (lower energy). The incoming (excitation) beam
and the outgoing (fluorescent) light are separated by a beam splitter of dicroic
mirror. The emission filter refines the light beam before reaching the detector.
principle is easy. The incident excitation beam if necessary is filtered to the optimal
wavelength by an excitation filter to illuminate the object. To direct the emitted light
to the detector, the path of incident and emitted beam have to be separated either by
a simple beam splitter, or a dichroic mirror that reflects or lets light pass according to
the wavelength. The emission filter lets pass only the light from the emission spectrum
of the fluorophor, so noise signal of any other wave length (especially reflexions from the
strong excitation beam) are filtered out.
2.1.2. Laser Scanning Confocal Microscopy
The confocal principle was first described by Minsky in 1957 , however it did not become
known and used until 1988, when scanning techniques were elaborated enough to allow
for a good reconstruction of the image.
The principle of confocal microscopy [67], [68] is as simple as striking: The main idea is to
use the light from the plain that is in focus and exclude out of focus blur. This is imple-
mented by illuminating the sample through a pinhole, while another pinhole is placed in
the plain of the virtual image in front of the detector. It is placed so that it lets pass only
light from exactly the one illuminated point of the in focus object, while all light from
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Figure 2.3.: The confocal principle: the setup of a laser scanning fluorescent confocal microscope
is based on fluorescent microscopy setups, the pinhole filters out light from other
layers than the layer in focus, therefore 3D imaging is possible.
other points of the plain or other out of focus plains is debarred as depicted in Figure 2.3.
To obtain a complete image, the points of the object are scanned one after the other and
then composed together to a virtual image. By scanning the other plains, it is possible
to get a 3D image of the observed object.
Due to the scanning technique there is no camera required, therefore photon multipliers
(PMT) or even more light sensitive avalanche photo diodes (APD) are used as detectors.
With the pinhole size it is possible to regulate the thickness of the plain from which light
is still detected: the bigger the pinhole, the more light from diﬀerent plains can reach the
detector, with this the image becomes brighter but resolution in the vertical direction
(z-direction) is decreased. For pinholes about the size of an Airy Disc, z-resolutions up
to 300 nm can be reached.
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2.1.3. Spinning Disc Confocal Microscopy
For big objects, the scanning process takes time, decreasing possible time resolution.
Therefore came up the idea of scanning with 1000 pinholes at some distance at the same
time. These 1000 pinholes are installed on a disc, that can rotate to scan the object,
therefore called Spinning Disc. To allow for this, physically the same pinhole is used
for incoming and outgoing light, therefore the dichroic is also integrated in the disc.
Additionally the incoming laser is focussed on the pinholes for each with a little lens also
placed on second disc, the microlens Disc, that moves together with the pinhole disc.
Detection can not be done with one photomultiplier, but has to be carried out with a
camera, to resolve the signal form the single pinholes separately. The camera also allows
for a much higher light sensitivity than PMT detectors.
Figure 2.4.: The Spinning Disc is a method to accelerate scanning using 1000 pinholes at a time.
The pinholes serve as source pinhole and detector pinhole at the same time. They
are placed on a Disc, where the respective microlenses are arranged to focus the
laser beam onto the pinholes and the beam splitter is included to separate incoming
from outgoing light. (3i intelligent imaging innovations)
2.1.4. Signal Quantification and Signal Disturbances
My objective was to characterize receptor distribution, determining numbers of receptors
and oligomerization levels, therefore one main goal was to quantify signal and related
to receptor amounts. When using fusion proteins but also with antibody staining, the
receptor amount is proportional to the fluorophor amount, which in turn (upon equal
illumination) directly corresponds to the measured light intensity. Therefore intensity
values can directly be used for quantification of receptors. When using equal staining
techniques these intensities can be calibrated and thus receptor numbers counted.
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In every microscope image there are disturbances that cause measurement errors. There
are two main error sources: background and noise, that can be traced back to diﬀerent
sources of origin.
The background has a positive intensity value and is generated for example by autoflu-
orescence of cells, unspecific signal, surrounding light and light reflexion on the glass.
On the other hand noise is a measurement error on every single pixel of the image. It
originates for example from the detector e.g. from the PMT or the camera from the
amplification and read or as dark noise or the variation of the photons themselves, the
so called shot noise.
When acquiring images, one should try to reduce these sources of error of cause consider-
ing other features of the measurement such as time and spacial resolution, bleaching and
photo toxicity. Noise can be decreased relatively by acquiring more signal, e.g. if possible
with longer integration times, stronger illumination and stronger fluorescent dyes.
However there are also image processing techniques for reducing these sources of error:
Depending on the research question in cellular biology the background can be determined
locally (e.g. on a position inside the cell) or globally (a position outside the cell) and
then be subtracted from the image.
The distribution of the noise, that comes from the surroundings can be determined, but
since it is randomly distributed on every pixel, one can not subtract it from the image
like the background. However since the noise of diﬀerent pixels is independent (high
spacial frequency), while the signal mostly correlated over many pixels, smoothing (e.g.
with a Gaussian kernel or low pass filter) can reduce the noise. A similar method, when
the question allows for lower resolutions, is the merging of neighboring pixels, so called
binning, which reduces noise compared to signal.
The shot noise on the other hand is a physical property of light itself. It is named after
Walter Schottky, who discovered it on electric currents in vacuum tubes, but his findings
hold true the same for photons of fluorescent signal. Contrary to the other sources that
cause a constant noise, the shot noise is a statistic variation light intensity and therefore
is dependent on the amplitude of the signal itself.
Nshot =
￿
number of photons
Other error sources lye in the features of fluorescent dyes themselves: bleaching and
blinking of the fluorescent dyes, quenching e.g. by chemical substances (GFP is quenched
in the endosomal compartment of cells) but also uneven distribution of fluorescent dyes
on the observed molecules can lead to errors in the observation of biological processes.
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2.1.5. The Limit of Resolution
Microscopes are used to increase the resolution of objects that are not within the resolu-
tion of the normal eye. My goal was to observe single receptors on the plasma membrane
of cells. The resolution plays a key role to separate receptors and high resolution allows
for monitoring of clustering. However resolution is limited not only technically (by aber-
rations of the microscope) but particularly on a principle level by the diﬀraction of the
light by the optical aperture. Even with a perfectly built aperture a point-shaped light
source will appear as a small disc, called Airy Disc, caused by the diﬀraction of light.
It can be described by the square of a Bessel-function, however the gaussian function
represents a good approximation 2.5.
Figure 2.5.: The airy disc describes the intensity pattern, that results from diﬀraction when a
point source is imaged. It can be theoretically describes as the square of a Bessel
function (red) but very well approximated by fit to a gaussian function (black).
To define the resolution usually the Rayleigh criterium is used, which indicated that two
near objects can still be resolved as two, when the minimum between the two maxima
of the objects is 26% smaller than the maxima themselves. For a system that is limited
only by the diﬀraction of light, the resolution therefore results as:
resolution =
1.22λ
2n sin θ
(2.1)
where λ indicates the light’s wave length, n is the refractive index of the medium and
sin θ is the maximal angle of incidence achieve by the microscope objective. Ernst Abbe
combined n sin θ to the physical variable NA. the numerical aperture, thereby postulating
the Abbe diﬀraction limit:
resolution =
0.61λ
NA
(2.2)
To increase the resolution one can thus optimize the variables in this equation. In mod-
ern microscopes numerical apertures up to 1.4 are achieved, by high angles and optically
dense oil. Using light with small wavelength, e.g. UV-light, increases resolution, how-
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ever one has to consider, that biological object might be massively damaged by such light.
The resolution in the vertical direction of a confocal microscope is limited to 600 nm.
It is determined by the pinhole and can be increased by reducing pinhole size. This
is however accompanied by a decrease in light, reducing the signal. In 4π- microscopy
the use of two objectives from both sample sides allows for duplication of the angle and
therefore increases vertical resolution.
The Point Spread Function
To characterize the features of optical systems however not always the resolution but
rather a so called point spread function is used, which is defined as followed: Between
the observed object and the virtual image there is the optics of the microscope, that
generates aberration eﬀects and the diﬀraction eﬀects described by Abbe.
The point spread function specifies as a direct function of
space, how a point source will appear on the virtual image.
With an optimal optical system, this corresponds well to the Airy Disc and can be ap-
proximated with a normal distribution (Gaussian function). To experimentally determine
the point spread function of a microscope one has to acquire the image of a point like
object, such as a fluorescent bead much smaller than resolution, e.g. 20 nm
The Pixel Size and Sampling
As discussed earlier in Laser Scanning Microscopy objects are scanned point wise and
then represented. Every point results into a pixel on the virtual image. This corresponds
to a discretization on a continuous object, where the point distance corresponds to pixel
size and has to be appointed reasonably. Since the image resolution is limited by the
diﬀraction law, much higher pixel resolution is not necessary. Nyquist put this into a
theorem stating:
For a function with resolution d - meaning minimal frequencies
of 1/d - a sampling of d/2 contains the maximal information.
Therefore one should choose a pixel size d/2 to achieve maximal resolution without over-
sampling.
As I will show via simulations, that resolution has a key role in the imaging and quantifi-
cation of receptors and oligomerization, therefore I performed high resolution microscopy
in collaboration with Matthias Reuss.
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2.2. Stimulated emission depletion
One limiting factor when observing receptor clustering microscopically is spatial reso-
lution. Our goal is to separate receptors that randomly near, but still in the order of
magnitude of 50 nm distance from receptors that cluster. For this, I collaborated with
Matthias Reuss to perform high resolution microscopy.
One of the most important high resolution techniques is Stimulated Emission Depletion
(STED) microscopy which was described and experimentally realized in the 90s by Stefan
Hell [69]. The basic idea holds true for most super-resolution methods known today. It
is to isolate dyes whose diﬀraction-limited images would normally overlap by switching
them between a fluorescent bright and a non-fluorescent dark state sequentially. This
way, they can be imaged one after another and thus be located separately. In contrast
to high-resolution techniques such as PALM and STORM that rely on random switching
and subsequent in-silico localization of individual emitters, STED is based on confocal
laser scanning and localization is established in the sample itself. By keeping molecules
at the periphery of the confocal excitation spot dark via stimulated emission, the area
in which molecules are allowed to fluorescence is eﬀectively shrunk and this way the res-
olution can be increased beyond the diﬀraction barrier.
Figure 2.6.: The STED principle: Jablonski diagram of fluorophores, normally energy release
occurs via emission of fluorescent light. In STED-microscopy molecules are relaxed
by stimulated emission without emitting fluorescent light.
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As depicted on the Jablonski diagram in Figure 2.6 exited fluorophores can release their
energy by spontaneous relaxation, resulting in fluorescence. In STED this stimulated
emission is enforced by irradiation with a depleting laser of a similar wave length to the
exciting one.
To achieve a higher resolution the exiting laser is focused to a diﬀraction limited spot,
Figure 2.7 (blue). The wavefront of the depletion laser is modified leading to a donut-like
shape (red). The exited molecules only fluoresce in the spot (green), where they are not
depleted.
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Figure 2.7.: Shape [70] and intensity profile of exiting and depleting laser result in a highly
resolved fluorescent spot. When the depleting laser power is increased, higher reso-
lution is achieved (dotted lines).
By increasing laser power of the depleting laser (dotted lines) more molecules are switched
oﬀ as depicted in the intensity diagrams. The spot in which fluorophores are able to signal
has a diameter of
d =
λ
2(NA)
￿
1 + Im/Isat
where Im is the intensity of the depletion beam at its maximum and Isat is the saturation
intensity of the fluorescent molecule, a characteristic quantity normally in the range of
1MW/cm2. Outside this radius practically 95% of the molecules are switched oﬀ [71].
To achieve this resolution laser powers for the STED-laser are chosen in the range of
200MW/cm2. The high laser powers make alignment of the depletion laser crucial. No-
tably the intensity of the depletion laser in the centre of the donut, where molecules
should give signal, needs to be set to 0, so that the wanted signal is not reduced. The
depleting laser does not have the right wave length to bleach molecules directly, however
the high energies can indirectly cause bleaching [71].
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The STED setup is essentially a (confocal) laser scanning microcopy setup, where a sec-
ond laser, the depleting laser is coupled in via a second dichroic mirror. A beam shaping
device forms the characteristic donut shape of the depleting laser, Figure 2.8.
Figure 2.8.: STED setup: the setup essentially follows the setup of a (confocal) laser scanning
microscope. With a second dichroic mirror the depleting laser is coupled into the
light path. A beam shaping device forms the characteristic donut shape of the
depleting laser. [72].
When molecules are continuously excited by a continuous wave laser (CW) a high num-
ber of molecules is continually in the excited state, from where they can cross over into a
triplet state which is a known source for photo-bleaching Therefore often pulsed exciting
lasers are used. The depleting laser can be used in continuous wave modus or be pulsed
as well and triggered to the exciting pulse with a adjustable time delay, in order to only
illuminate the sample, when molecules are in the excited state.
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Point Spread Function
Contrary to the confocal systems the resolution is not determined by the optics of the
microscope but by the switching oﬀ via depletion of molecules together with the fact that
the location of the molecules that are allowed to remain in an on-state is established by the
position of the donut-null, which in turn is positioned by the scanner. The point spread
function that characterizes the resolution can for pulsed STED beams again be well
approximated by a – now narrower – Gaussian function. However, incomplete switching,
re-excitation or simply autofluorescence is often the cause for an additional pedestal of
confocal width; then the true PSF is the sum of a confocal PSF with a Gaussian STED
peak that can be approximated by a Lorentz function, Figure 2.9.
Figure 2.9.: The point spread function of STED microscopy is determined by the depletion
of molecules next to the peak of resolution. The highly resolved peak and the
characteristic basement around the peak is described by a Lorentz function.
STED is still developed further, aiming for simpler setups, where lasers are intrinsically
aligned [73] and faster scanning setups [70], [74].
For the observation of receptor clustering resolution is a key issue and the high res-
olution techniques STED can give very far insights into receptor clustering. However
protein dynamics measurements are more accessible and provide a robust instrument for
observation of clustering also at very high receptor concentrations.
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2.3. Protein Dynamics and Clustering
The naive idea of measuring clustering by dynamics is, that particles of bigger size should
be diﬀusing slower and thus clustering should be possible to be diagnosed by a decrease in
diﬀusion coeﬃcient (a slowdown). Saﬀmann and Delbrueck focussed particularly on the
diﬀerences between lateral diﬀusion in membranes and the more simple three dimensional
diﬀusion in a bulk. Focussing on the CD95-receptor in the following I want to constrain
to the case of a transmembrane proteins.
2.3.1. Diﬀusion Models
Theoretically the publication of Saﬀmann Delbrueck indicates a weak logarithmic depen-
dency of the diﬀusion coeﬃcient on the size of the protein [75]:
D ∝ ln(R) (2.3)
D represents the diﬀusion coeﬃcient and R is the radius of the transmembrane protein in
the plain of the membrane. The third dimension outside the membrane can be neglected.
For a long time theoretical approaches were based on this. However Gambin et. al.
[76] have called into question this equation with experiments on artificial membranes.
Considering literature data and their own experiments, they found that heuristically the
dependency of the diﬀusion coeﬃcient on the size can be described as a linearity in a
Stokes-like expression.
D ∝ 1
R
(2.4)
Naji in 2007 [77] could theoretically support this finding arguing that ”whenever the
protein-lipid interactions locally deform the membrane, that deformation generates new
hydrodynamic stresses on the protein-membrane complex leading to a suppression of its
mobility.” They suggest two eﬀects and show that both theoretically lead to a D ∝ 1/R
scaling. One being enhanced dissipation associated with modifications of the flows in the
solvent, the other being enhanced dissipation in the membrane itself, when local compo-
sitions, chain stretch or tilt order are changed. Guigas [78] modeled the eﬀect of internal
degrees of freedom of the included complex on the diﬀusion coeﬃcient (not including
upper membrane deviating) showing an eﬀect of D ∝ 1/R2.
Therefore diﬀusion coeﬃcients can be used to measure the oligomerization of transmem-
brane proteins. While the function of size is only very weak (logarithmic) for some
particles and especially for lipid domains, for the majority of transmembrane proteins
there could be shown a linearity like in 2.4 experimentally and theoretically accounted
for.
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Since there are no structural data for CD95, the transmembrane radius, and structure
of interaction of CD95 can only be estimated, so that a measurement of the diﬀusion
coeﬃcient can only yield qualitative but no quantitative statements on oligomerization.
2.3.2. Membrane Models
There are diﬀerent models for the composition of the plasma membrane and its influence
on the diﬀusion of proteins:
Figure 2.10.: Original figure from Singer and Nicolson (1972) depicting membrane cross sec-
tion with integral proteins in the phospholipid bilayer mosaic. Phospholipids are
depicted as spheres with tails, proteins as embedded shaded, globular objects. Pe-
ripheral proteins, which would be situated at, not in, the membrane surface, are
not shown. Transmembrane protein spanning entire membrane on left.
The simplest model is the fluid mosaic model of Singer and Nicolson [79]: which assumes
a laterally homogeneous lipid membrane. The associated proteins can diﬀuse freely
with Brownian motion in the plain following the findings of Saﬀman and Delbrueck de-
scribed earlier [75]. However in the real cell plasma membrane protein diﬀusion becomes
sometimes anomalous [80]. Also diﬀusion coeﬃcients are much lower than in artificial
membranes [81]. There are various reasonings to explain this slowdown. Retardation is
possibly due to protein protein interactions active transport, cytoskeleton interactions
and confinement and membrane lipid microdomains [82].
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Therefore the diﬀusion coeﬃcient D may diﬀer between short distances (e.g. in a raft or
within a mesh of the cytoskeleton) and long distances, covering many rafts or scaﬀolds.
Diﬀerent measurement techniques for the diﬀusion coeﬃcient therefore provide local or
global values. Fluorescence correlation spectroscopy (FCS) measures local values, while
fluorescence recovery after photobleaching (FRAP) can also be set up for long distance
measurements of diﬀusion. [83] gives a good review on the diﬀerences between many of
these techniques and the insights to the structure of the plasma membrane achieved with
diﬀusion measurements.
2.4. Fluorescence Recovery after Photobleaching
In the 70s biologists started using fluorescence photobleaching recovery as a tool to study
localization and dynamics of biomolecules. In the experiment locally a small part of fluo-
rescent molecules, that are to be observed, is irreversibly bleached and the redistribution
of the unbleached molecules is observed. There are several reviews that cover the diﬀer-
ent methods and the applications of FRAP: Reviews: [84], [85], [86].
With this method already various interesting discoveries could be made regarding local-
ization and dynamics of proteins and also interaction with other components in living
(in vivo) cells [84].
The fact, that in many cell compartments molecules diﬀuse freely and are not bound,
could only be shown by FRAP - e.g. in the mitochondrial matrix [87], in the nucleus
[88], in the cytoplasm, in the ER-lumen [89] andin the ER- and Golgi membranes [90]
While previous considerations and studies ”suggest that the mitochondrial matrix, if it
is indeed a crowded protein solution, would severely hinder solute diﬀusion” Partikian
et. al. could show with FRAP experiments, that this hindrance ”relatively mild” and
proteins can diﬀuse nearly as freely in the matrix as in aqueous solution [87].
Also the retention of proteins in the ER and Golgi is not achieved by immobilization
[90]. The transport of proteins through membrane traﬃcking pathways could be studied
in detail revealing: ” protein traﬃc through the various compartments of the secretory
pathway” ”compartment residence times and rate constants” for delivery form ER into
Golgi and to plasma membrane transport mechanisms [91][92]but also behavior during
mitosis [93]
But not only mechanisms of long range directed and diﬀusive transport could be studied,
also the study of dynamics of proteins in one compartment can bring insights on cel-
lular mechanisms. Notably mobility measurements of cell surface-proteins, with altered
mobile fraction can illustrate interaction with cytoskeleton element of the extracellular
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matrix. A list of biological processes, that have been studied with FRAP is displayed in
table 2.1. One has to carefully consider, which are the driving forces of movement of the
fluorescent molecules and which are the conditions of the experiment in order to chose
the right experimental and analysis method for FRAP.
diﬀusion coeﬃcients in cellular compartments or on
membranes: free movement, hindered diﬀusion
[84] [87] [94] [90] [89] [88]
anomalous diﬀusion [95]
directed movement such as flow [96]
interaction with other cellular components: e.g. other
proteins, cytoskeleton, extracellular matrix
[84]
binding rates: e.g. to the plasma membrane [97]
conformational changes [84]
exchange of labeled proteins between compartments:
e.g. protein traﬃcking
[91][92][90]
Table 2.1.: List of protein and cell features, that can be studied by dynamics measurement,
notably fluorescence recovery after photobleaching (FRAP)
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3.1. Chemicals, Antibodies, Stable Cell Lines
Cell culture
HeLa cells and all deriving clones were maintained in DMEM (GIBCO, Ref. 11960-044
500ml, 444689, 1056) with 10% fetal calf serum (Gibco-BRL) in 5% CO2, L-Glutamine
at 1% (Invitrogen) and Penicillin/Strepdavidin at 1% (MERCK)
Antibodies
Fas (human), mAb (APO-1-3) anti CD95 mouse antibody, lgG3, Enzo life sciences,
Lausen Switzerland, 1mg/mL, monoclonal
Fas (human, mAb (APO-1-1) anti CD95 mouse antibody, lgG1, Celonie GmBH mon-
oclonal mouse antibody, not agonistic to CD95, 1mg/mL, mono-clonal
Alexa Fluor 488 Goat Anti-Mouse lgG (H+L) anti mouse antibody, lgG (heavy and
light chain), Molecular Probes (Invitrogen), 1mg/mL, polyclonal
Anti-Mouse-lgG - Atto 647N antibody produced in goat anti mouse antibody, lgG,
SIGMA (50185), 0.8mg/mL, polyclonal
Transfection
Transfection of the diﬀerent constructs was obtained with FuGene (R 6 Transfection
Reagent, Roche) following the protocol. To allow localization of the receptor from the
endoplasmic reticulum to the plasma membrane, experiments were performed two to four
days after transfection.
Fibronection-coating on microscopy chambers
For live cell microscopy Labtek chambers (8-well) were used. To achieve a flat attachment
of cells on the glass, chamber were coated with fibronectin. Every well was incubated
with 50 µL Fibronectin at concentration 1mg/mL for 1 h, solution was removed with a
pipet and the chamber kept at 37◦C until use.
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Constructs
shRNA-knockdown (2157)
GATCC AGCGTATGACACATTGATTC TCAAGAGAAA TCAATGTGTC ATACG
CTTCT TTTTT GGAAA
The shRNA against CD95 (coding sequence within the death domain) was cloned in
pSilencer3.1-neo and stably expressed in HeLa cells (as later described). The shRNA is
combined with a resistance against G418.
In the case where full length receptors were expressed in the stable knockdown cell line,
we used a mutant form that minimizes the recognition of the shRNA while conserving
the amino acid sequence.
The following receptor constructs were all expressed under the CMV-promoter.
Fluorescent proteins were fused to the C-terminal, intracellular part, of the receptor with
the linker GGGGGPVAT.
The numbering used in the following, represents the receptor in a full length coding
including the signal peptide.
CD95-wt-mGFP (1127)
Wild type receptor fused to mGFP, a form of GFP, that minimizes dimerization.
CD95-C199V-mGFP (1208)
In this construct a cystein in the intracellular part of the receptor (between death domain
and transmembrane domain) is mutated into a valin. According to Chakrabandhu et al.
[42] this cystein serves as a palmitoylation site and palmitoylation is inhibited in the
mutant.
CD95-∆(210-335) (1208)
This construct is a receptor lacking the death domain (nucleotid 210-335) in the intra-
cellular part of the receptor. Therefore it can not recruit FADD after induction. The
CD95-knockdown shRNA does not aﬀect expression of this mutant, since it is directed
against the lacking domain.
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Stable clones
Stable clones were produced by transfecting HeLa cells with the vector (1-2 µg) contain-
ing the protein of interest (or shRNA) and a resistance to either puromycin or G418.
Three days later transfected cells are incubated with medium containing the respective
antibioticum (G418 at 0.8-1.2mg/mL, puromycin at 1-2 µg/mL) to start the selection
process for those cells that were transfected by the vector and therefore are resistant to
the antibioticum. When 100% of the control cells are dead, the resistant cells are highly
diluted and single cells are selected (e.g. by plating at low concentration into 96-well
plates, leading to one cell per well). Single cells are now maintained (and let propagate)
to yield a population of one single clone. The clones are then tested, e.g. by measuring
the content of protein of interest or the function of the protein of interest, to choose the
clones with the desired features.
CD95-hE (high expression levels)
Stable HeLa clone (produced by Joël Beaudouin in the laboratory) that expresses CD95
at high expression levels of 200.000 receptor per cell, chapter 4.1.2. Puromycin-resistent.
Laboratory name: Apo-#12
CD95-GFP-hE (high expression levels)
Stable HeLa clone produced by Joël Beaudouin in our laboratory that expresses CD95-
GFP at high expression levels of 140.000 receptors per cell, chapter 4.1.2. G418-resistent.
Laboratory name: Apo-mGFP-#1
CD95-kd
For production of the stable knockdown HeLa cells were transfected with shRNA (2157)
and knockdown eﬀect was verified by measurement of number of receptors. Figure 3.1
shows the histograms of the flow cytometry measurement of HeLa, the CD95-hE clone,
the transiently transfected knockdown cells and control cells. The transfected cells show
nicely two peaks, one peak of cells, that integrated the shRNA and therefore have a lower
amount of receptors than HeLa, the other peak of cells that did not integrate the shRNA
therefore coincides with non-transfected HeLa.
The knockdown cells were selected with G418 and clones chosen as described above. The
clones were then again tested for amount of receptor by flow cytometry and percentage
of cell death after three hours with high concentrations of ILZ-sCD95 was established,
counting by eye, Figure 3.2. The clone used for further experiments was the one indicated
with number 2.
Laboratory name: kd-#21
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Figure 3.1.: Flow cytometry measurement of transient transfected knockdown cells. The tran-
siently transfected cells show two peaks. The left peak are cells that integrated
the shRNA and therefore have less receptors. The right peak are the cells, that
did not integrate the shRNA and therefore have the same amount of receptors as
non-transfected HeLa cells.
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Figure 3.2.: Characteristics of stable knockdown clones. The number of receptors on the cell
surface was determined by calibrated flow cytometry as described in chapter 3.3.
The percentage of cell death was determined visually after three hours of ILZ-
sCD95L induction.
CD95-GFP-pE (physiological expression)
To achieve a stable cell line with physiological expression fluorescent receptors, the stable
clone CD95-kd was used, where endogenous receptor is knock down and that is already
resistant to G418. Therefore the vector contained the mutant form of CD95 (minimized
49
3. Materials and Methods
recognition by shRNA) and a resistance to puromycin. Clones were selected according
to death test and receptor amount similarly to the example above.
Laboratory name: Fas-GFP-#7
3.2. Immunostaining
The immunostaining protocol of HeLa cells for confocal microscopy was optimized build-
ing on a protocol existing in the lab. The goal was to observe the receptor distribution as
is it in living cells without artifacts. Notably one disturbance, the cross linking of recep-
tors by the primary antibody could sometimes be observed in the clone overexpressing
CD95-GFP (CD95-GFP-hE). Therefore fixation was optimized on this clone, to avoid
crosslinking.
Buﬀers: Fixation buﬀer: HBSS (Hank’s Balanced Salt Solution, 10x, GIBCO Ref: 14065
-049, CaCl2 +MgCl2), 0.1M sucrose (ubs / SIGMA), 4% PFA (THERMO scientific,
Prod# 28908,16%), 0.1% GA (Glutaraldehyde 25% ). Blocking buﬀer: HBSS, 0.1M
sucrose, 1%BSA (Albumine Bovine Serum, Feststoﬀ, SIGMA)
Sample preparation for microscopy: HeLa are plated on those cover slips that are later
used for microscopy one day before, precool HeLa 5min, flush with HBSS, fix 30min
with fixation buﬀer, wash with washing buﬀer (HBSS, 0.1M sucrose), block three
times 5min with blocking buﬀer, incubate 1 h with primary antibody (Apo 1-3,
c = 10 µg/mL) at 4◦C, wash three times 5min with blocking buﬀer, incubate 1 h
with secondary antibody (Alexa 488 α-ms, Atto 647N α-ms) at 4◦C, wash three
times 5min with blocking buﬀer, wash quickly with Millipore water, mount with
mounting medium (confocal: Fluoromount, STED: Mowiol), dry over night.
Sample preparation for flow cytometry: To reach a reasonable amount of cells for mea-
surement, 500.000 cells are used for this protocol. Cells are detached by trypsina-
tion and washed with 10mL PBS. Cells are fixed for 30min with fixation buﬀer,
for the following steps, the protocol above is followed, where washing is intended
as incubation with 10mL buﬀer and subsequent centrifugation and resuspension
of the cells. Calibration beads (QIFIKIT) are washed once and then incubated
with secondary antibody and prepared, following the protocol for cells. Instead of
mounting, cells are suspended in 50 µL PBS.
3.3. Flow Cytometry
To quantify the receptor on the plasma membrane, we performed quantitative flow cy-
tometry using calibration beads. Cells were tripsinated, washed with DMEM, fixed with
4% PFA and stained with monoclonal Apo1-3 and anti-ms-Alexa488. Cells were not
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permeabilized in order only to stain the receptor on the plasma membrane.
For fluorescence measurements a flow cytometry system FC500 / MPL (Beckman Coul-
ter) was used. It has a 488 nm, 20mW Argon Laser is used for excitation. A setup with
various dicroic interchangable dicroic filters redirects the light to forward scatter, side
scatter and fluorescent detectors.
The fluorescence measure in arbitrary units, however it is proportional to the number
of fluorescent molecules and assuming an equally distributed staining, it is proportional
to the number of receptors on cells. Fluorescence was calibrated using calibration beads
with defined number of primary mouse antibodies, that are staining following the same
protocol as the cells, Figure
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Figure 3.3.: Histogram of calibration beads is used to quantify receptor levels on cells: HeLa cells
and calibration beads are stained following the same protocol, the known number of
mouse antibody on the five populations of the calibration beads allows for a direct
comparison of the logarithmic intensities of stained cells and control cells.
The number of antibodies N for every peak is provided by the manufacturer and mean
fluorescence intensities for the beads MFI as well as for the cells Icells are estimated from
the histogram.
log(N) = m · log(MFI) + n ⇐⇒ Nrec = Ncell −Ncontrol
3.4. Confocal Laser Scanning Imaging
Images were acquired with a Leica SP5 confocal laser scanning microscope.
Laser 488 nm
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3.5. Fluorescence Recovery after Photobleaching
FRAP analysis was performed on a Leica LSM SP5 microscope equipped with an Ar 488
nm laser. A stripe of 2 µmm width was bleached on the lower plasma membrane of the
cells and relative fluorescence intensities were measured. By measuring the widening of
the stripe after bleaching the diﬀusion coeﬃcient was estimated.
Pixel size was set to 247 nm, which with a stripe width of about 2 µm allows still for a
good spatial resolution even if not maximal Niquist sampling. With a scanning speed of
1000Hz and an image size of 256 pixel, this allows for a time resolution of 0.28 s. This
leads to an intensity signal of about 29 (arbitrary units) with a noise standard deviation
of 12, which still allows for a good fitting of the gaussian profile.
To allow for an automated measurement of cells after induction the autofocus modus of
the microscope was used. Autofocus is typically measured in reflection mode. At very
low resolution and very little frame size (64 x 64 pixels) a user-defined z-range is scanned
and highest intensity estimated, corresponding to the level of the glass surface, where
the laser is reflected. The next image is then taken at a user defined distance from the
glass (for the lower membrane typically around 0.3 µm).
3.6. Spinning Disc Confocal Imaging
I want to kindly thank the Nikon Imaging Center der Universität Heidelberg for the
possibility to use their devices for Spinning Disc confocal imaging.
The confocal spinning Disc images were acquired on a Perkin Elmer spinning disc con-
focal ERS-3 on a Nikon Eclipse Ti inverted microscope using the laser line 488 nm. The
system is equipped with a highly sensitive Hamamatsu EM-CCD camera C9100-50 (sen-
sitized emission method) with a pixel size of 83.4 nm and a 100x 1.4NA Plan Apo Oil
objective.
The following parameters were used for image acquisition: Laser Power: 75%, AOTF:
100%. field of view: 100 µm2, exposure time: 2 s, EM-Gain camera: 120. To allow for
highest possible resolution the z-step size was chosen 0.15 µm and no binning in xy was
applied to meet the Nyquist sampling theorem.
3.7. Stimulated Emission Depletion Microscopy
The stimulated emission depletion images were acquired on a STED system, built in
house by Matthias Reuss in the Department Optical Nanoscopy of the German Cancer
Research Center. The system consists of a Leica DMI6000 stand, where external pulsed
52
3. Materials and Methods
lasers were coupled in for excitation and STED. For beam scanning, a home-built ”Quad-
Scanner” was used as described in [74].
For excitation a pulsed laser diode (Picoquant, Germany) was used at a wave length of
634 nm, triggered by the STED-laser via optical pickup using a fast photodiode (PDM-
400, Becker & Hickl, Germany). The STED laser was a Titanium:Sapphire laser (Spectra
Physics, Canada, repetition rate 80MHz used at a wave length of 750 nm The pulses were
stretched to ≈200 ps by sending them through 50 cm of NBK5 glass followed by a 100m
long single-mode polarization-maintaining fiber (OZ Optics, Canada). The STED inten-
sity was about 70MW/cm2 in the focal plane.
The following parameters were used during image acquisition: pinhole size: 1 Airy disc,
dwell time: 100 µs/ pixel, field of view: 100 µm2, pixel size: 20 nm. The excitation power
at the back focal plane was 10 µW, the STED power 100mW.
3.8. Dot Segmentation Image Analysis
Stefan Wörz, in our department developed an image processing tool for the segmenta-
tion of point-like structures with intensity profiles similar to two or three-dimensional
gaussian functions [98].
Stefan’s Tool 
-> Montage 
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Figure 3.4.: Dot Segmentation. The background is determined as the maximum of the intensity
histogram of the image. The threshold for spot detection is determined as T =
µh+ fσh where µh and σh denote the mean and standard deviation of the intensity
histogram and f is an adaptable parameter.
The program works in several steps, Figure 3.4. At first images are smoothed with a
gaussian filter of width (ω · pixel size) to reduce noise. Then a threshold T = µh + fσh
is defined , where µh and σh denote the mean and standard deviation of the intensity
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histogram of the whole image. f is a free scaling factor, that has to be sensibly adapted
to the image. With this threshold local maxima are determined, that are considered as
spot candidates. Every spot candidate is then fitted to a gaussian function. For this fit
also a radius of the fitting area can be adapted rROI. The fit results in an eﬀective local
background subtraction. Various adaptable rules are implemented, that define how to
proceed with overlapping spots, ellipsoid spots, spots of relatively large or small intensity,
contrast or size. The output of the program is a list of spots and their features such as
integrated intensity I, contrast c = amplitude of gaussian to local background, x-, y- and
z-position, size and many more.
Depending on the experiment and the biological question, that the images originate from
the appearance can be very diﬀerent: e.g. what structures are images, how close and
dense they are located, local and global background, pixel size, but also the composition,
resolution and brightness of the structures. Therefore various parameters in the tool are
freely selectable and need to be adapted to the respective image.
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4.1. The Number of Receptors per Cell
4.1.1. Quantification of CD95 by Flow Cytometry
To characterize the receptor on the plasma membrane my first goal was to estimate
number of receptor that are on the plasma membrane to be able to determine receptor
concentrations.
To quantify the receptor on the plasma membrane, we performed quantitative flow cy-
tometry using calibration beads. Cells were fixed and stained with monoclonal Apo1-3
and anti-ms-Alexa488. Cells were not permeabilized in order only to stain the receptor
on the plasma membrane.
Fluorescence of a whole cells is measured by flow cytometry and yields an intensity value
in arbitrary units. These units can be calibrated using calibration beads. These beads are
consist of 5 populations with a defined number of mouse epitopes on the surface. They
are stained with the same protocol as the cells and since fluorescence in proportional to
the number of fluorescent molecules on the surface, they are used to calibrated the inten-
sity scale to numbers of receptors. An example of fluorescence intensity distributions of
these beads and of HeLa cells is shown in Figure 4.1, note that the fluorescence intensity
is depicted on a logarithmic scale, therefore lognormal intensity distributions appear as
gaussian bells. The control consists of cells, stained without the primary antibody and
represents the unspecific staining and autofluorescence. To estimate the number of re-
ceptors per cell, the median for HeLa and control are subtracted and calibrated again
the beads as described in chapter 3.3.
It has been proposed that binding of the primary antibody is hindered by fixation, there-
fore I tried incubation with the primary antibody (Apo 1-3 and Apo 1-1) before and after
fixation, Figure 4.2. There is not a massive diﬀerence in fluorescence intensities, when
fixing before or after the primary antibody, showing that the antibody can still bind
after fixation. Therefore to avoid long detachment times of living cells, in all further
experiments cells were fixed before staining.
I tested both antibodies to know whether staining they both work well and especially
with fixation before staining, results are very similar, Figure 4.2.
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Figure 4.1.: Histogram of calibration beads is used to quantify receptor levels on cells: HeLa cells
and calibration beads are stained following the same protocol, the known number of
mouse antibody on the five populations of the calibration beads allows for a direct
comparison of the logarithmic intensities of stained cells and control cells.
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Figure 4.2.: Protocol optimization. Left: fixation does not hinder antibody binding, since both
peaks show similar intensities. Therefore fixation should be performed before stain-
ing, to avoid long detachment times of living cells. Right: both antibodies yield
similar fluorescence values, therefore in future either one can be used.
4.1.2. The Typical CD95 Expression is roughly 10000 Receptors per Cell
My goal is to characterize the receptor on the plasma membrane notably determining
clustering and oligomerization levels at diﬀerent receptor concentrations. High expression
levels can easily be achieved with transient transfection (also a stably high expressing cell
line was produced by Joël Beaudouin in the lab, CD95-hE and CD95-nGFP-hE, chapter
3.1). For low expression levels I produced stable knockdowns as describes in chapter
3.1. For observation in living cells, I produced a clone stably expressing CD95-mGFP at
physiological expression levels in the knockdown.
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Using this protocol, I determined expression levels of diﬀerent cell lines: HeLa cells, clones
highly expressing the receptor (CD95-hE) or the receptor fusion (CD95-mGFP-hE), the
receptor knockdown clone (CD95-kd) and the clone expressing physiological levels of
fluorescent receptor (CD95-pE), Figure (6.1). Error bars represent the estimated mea-
surement error, when averaging over experimental replicates.
receptor number error
CD95-hE 200000 -
CD95-mGFP-hE 100000 -
HeLa 21249 1328
CD95-pE 9937 4000
CD95-kd 2705 1675
Panc1 8023 2430
T98G 6397 837
LN18 7040 2000
Jurkat 13000 -
Table 4.1.: Mean number of receptors per cell estimated by flow cytometry. High expression is
about 10 times higher than physiological expression, while the knockdown reduced
receptor amount about 3 fold. Error bars represent the estimated measurement error,
averaging over experimental replicates (not cell to cell variation).
The mean number of receptors on HeLa cells is about 20.000. High stable expression
yields about 10 fold higher expression. The knockdown clone contains about one third
of the receptor amount. I produced a stable line, expressing CD95-GFP at physiological
expression levels, making allowing for live cell experiments at physiological expression
levels.
Some other cell lines: neuronal, pancreatic and lymphocyte were tested and had similar
expression levels as HeLa, indicating, that measurements at physiological expression
levels are also relevant for a wider range than HeLa.
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5.1. CD95 resides into Dots at the Plasma Membrane upon
Induction
Our goal is to characterize the receptor localization and distribution on the plasma mem-
brane, especially focussing on receptor clustering on the plasma membrane. To reach this
aim, a GFP-fusion of the receptor was expressed at high levels in HeLa cells imaged by
confocal laser scanning microscopy.
(a) plasma membrane (b) endoplasmic reticulum
Figure 5.1.: HeLa cells, 3 days after transfection with CD95wt-GFP. (a) CD95wt-GFP is ho-
mogeneously distributed on the outside the cell if located at the plasma membrane
(b) it forms a net-like structure inside the cell, when located in the endoplasmic
reticulum. Top: lower part of the cell. Bottom: section of the cell. Scale bar 10µm.
One challenge is to only observe the receptors that are on the cell surface and not those
inside internal traﬃcking pathways. Therefore receptors were imaged three to four days
after transfection, which gives enough time for the transport from the endoplasmic retic-
ulum to the plasma membrane. Moreover we studied only the receptors that appeared
homogeneously distributed on the plasma membrane and discarded those that localized
in a net-like structure of the endoplasmic reticulum in the inside of the cell, Figure 5.1.
Another challenge is to achieve even images that allow quantification of the receptor
distribution. Therefore we imaged the lower plasma membrane, that lies flat in one layer
unlike the filipodia at the top of the cell, Figure 5.1. In order for the membrane to attach
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evenly on it, the glass was coated with fibronectin before plating the cells as described
in chapter 3.1.
Using this protocol it was possible to observe the behavior of the receptor on the plasma
membrane after induction: within one hour after induction with relatively high ILZ-
sCD95L concentrations (killing within 30-60min) the pool of evenly distributed receptors
contracts into dots at the plasma membrane (Figure 5.2). The structures are highly
dynamic, Figure 5.3.
Figure 5.2.: Upon induction dots form on the plasma membrane. HeLa cells transfected with
CD95wt-GFP. Left: before induction. Right: after one hour induction with ILZ-
sCD95L the receptors form dots at the cell surface. Scale bar: 10µm
Figure 5.3.: The dots that form on the plasma membrane are diﬀusing visibly. HeLa cells trans-
fected with CD95wt-GFP. In a time lapse microscopy after induction with ILZ-
sCD95L at high time resolution (same settings as used for fluorescence recovery
after photobleaching). The structures change their position regularly (within the
marked ROIs). Images at a frame time of 1.3ms. Scale bar: 5 µm
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To test whether the dot formation is correlated with the death-inducing function of the
receptor, we used diﬀerent inducers and studied their ability to form CD95 dots.
The agonistic antibody Apo1-3 induces similar dots as the ILZ-sCD95L, Figure 5.4(a),
when used at concentrations of 1 µg/mL, a concentration that kills cells on the same
time-scale as the high concentrations of ILZ-CD95L (data not shown).
When using the non-agonistic antibody Apo1-1 at the same concentration, we did not
observe the same formation and dynamics of the dots, Figure 5.4(b). Rather patch-like
patterns appeared mainly at the connections between two cells, which indicates that re-
ceptors are not crosslinked on the same membrane, but diﬀerent membrane patches are
crosslinked by the antibody. The Apo1-1 antibody is not able to induce cell death and
does not form the typical receptor dots on the plasma membrane, indicating that these
dots might correlate with the death-inducing function of the receptor.
(a) Apo1-3
(b) Apo1-1
Figure 5.4.: Diﬀerent inducers form diﬀerent receptor patterns: HeLa cells transfected with
CD95wt-GFP. Left: before induction. Right: after one hour induction with anti-
body at the concentration of 1 µg/mL (a) Apo1-3 form the typical dynamic struc-
tures. (b) Apo1-1 forms large patches at cell connections. Scale bar: 10µm.
There are various possibilities for the origin of these dots. Receptors could be clustering,
due to molecular interaction, be it the ligand, the receptor or the downstream proteins.
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Another possibility is the relocalization of receptors into lipid rafts on the plasma mem-
brane. A third diﬀerent alternative is the accumulation of internalized receptor into early
endosomes. To exclude the latter, one needs to test whether the receptors in the dots are
still inserted in the membrane and reach the outside or whether they are already inter-
nalized. The resolution of confocal microscopes is in the range of hundreds of nm, hence
we can not resolve structures of nm thickness, such as the plasma membrane and DISC
formation. Therefore to test whether the receptors in the dots are still on the cell surface,
live cells were induced to form dots, then cells were fixed and immunostained without
permeabilization, to allow the antibody to stain only targets on the plasma membrane.
Figure 5.5.: Dots can be immunostained and therefore reach the outside of the cells. HeLa cells
were transfected with CD95wt-cherry (red) and induced for one hour with ILZ-
CD95L. Then cells were fixed and immunostained with Apo1-3 mouse antibody and
antimouse-Alexa-488. Scale bar: µm
Figure 5.5 shows that some dots can be stained by the antibody, but also the receptors
on the plasma membrane, that are not located in dots are stained, forming a high back-
ground, that impedes good statistics and quantitative analysis. This however suggests
that parts of the dots are present at the plasma membrane and are not formed in early
endosomes.
To confirm this further, I performed staining of the early endosmes with a fluorescent
cherry construct of the Rab5 early endosome marker, while simultaneously imaging the
formation of the receptor dots as previously. The early endosomes do not colocalize with
the formed dots of receptors as can be seen in Figure 5.6.
I found formation of dots upon induction, that appear very similar to aggregated struc-
tures that were found mainly in type I cells by Siegel and Muppidi [37] but also in the
form of SDS-stable aggregates [38]. Upon antibody induction of Cos-7 cells and SKW 6.4
cells structures , named signaling protein oligomeric transduction structures (SPOTS)
were observed by microscopy. In Jurkat cells cap formation could be shown. SDS-stable
aggregates were mainly observed in type I cells (SKW 6.4 and H9) and typically were
about 90 to 200 kDA.
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Figure 5.6.: The dots do not colocalize with early endosomes. HeLa CD95 knockdown cells were
transfected with CD95-wt-GFP (green) and Rab5-cherry (early endosome marker).
Cells were induced for one hour with ILZ-CD95L and imaged as life cells. The
dots do not colocalize with the early endosomes excluding internalization as only
clustering mechanism. Scale bar: 5 µm.
In most of such studies antibodies instead of ligand were used for induction, since antibod-
ies most likely bind to diﬀerent epitopes than the ligand,also the transduction mechansms
might be diﬀerent. Therefore in this work mainly ligand induction was used to aim for
more physiological conditions.
Most studies also investigated in detail internalization, formation of structures such as
SPOTS and SDS-stable aggregates, and induction and signal transduction mechanisms
in type I cells. The one study involving HeLa cells mainly treats coculture experiments
and membrane bound ligand induction [44].
Therefore this work aims for the study of the type II cell line HeLa upon ligand induction.
I compare to structure formation, that has been observed in type I cells. A quantification
of dot distribution and size (number of molecules) will be carried out in chapter 5.2 to al-
low for a comparison with SDS-stable aggregates. To test whether function of structures
is similar in HeLa compared to type I cells, dot formation in diﬀerent clones, related to
the functions of lipid rafts and death domain aggregation was observed in chapter 5.4.
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5.2. Quantification of Dot Formation
based on the Dot Segmentation Tool by Stefan Wörz [98]
To quantify the kinetics of dot formation, I set up an image processing pipeline around
the central part for dot recognition: an Dot Segmentation Tool implemented by Stefan
Wörz for microscopy images, described in 3.8 and [98].
To allow for correct comparison between diﬀerent time points preprocessing, Figure 5.7
was adjusted to the specific experimental images and the question. The dot segmen-
tation using the automized Dot Segmentation Tool by Stefan Wörz is performed. For
the further processing and evaluation of the segmentation information I implemented a
Matlab tool, to determine intensity distribution histograms and compare the diﬀerent
time points.
-> Montage 
!"#$%#&'()*+,'#)
-&
.#
&*
/.(
)
-&
.#
&*
/.(
)
.0"#*0123)4)
5216,2)6,'75"1%&3)8)
21',2)).0"#*0123)4)
21',2)6,'75"1%&3)8)
!"#$%#&'()
-&
.#
&*
/.(
)
-&
.#
&*
/.(
)
!"#$%#&'()
!"#$!%&$#'()"*+,%
(!"&$!%&$#'()"*+,%-%
(!"&$!%./)01/"!,%2%
!"#$!%&$#'()"*+,%-%
!"#$!%&$#'()"*+,%-%
!"#$!%&$#'()"*+,%-%
Figure 5.7.: Pre-processing of images had to be adapted to the experimental question and the
features of the Dot Segementation Tool by Stefan Wörz. To allow for a comparison
of images of diﬀerent time points, the automatically set threshold has to be set
globally (Bottom) and not locally (Top). Therefore in a preprocessing step images
are combined into a montage in ImageJ.
To acquire time series data HeLa CD95 knockdown cells (CD95-kd) were transfected
with CD95-wt-mGFP as in the previous experiments, chapter 5.1, and induced with
ILZ-sCD95L. In order to observe cells for longer times, apoptosis was blocked using the
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caspase inhibitor zvad. Time lapse imaging was performed in collaboration with Joël
Beaudouin.
5.2.1. The Number of Dots increases over Time
To achieve optimal segmentation, images have to be preprocessed accordingly and pa-
rameters adjusted. The threshold for spot detection is defined by the image analysis
tool indirectly using the mean µh and standard deviation σh of the image histogram, as
illustrated in Figure 5.7(a).
For the experiments of this study however the goal is to compare images of the same cell
at diﬀerent time points, therefore the same threshold should be used. To achieve same
threshold settings, Figure 5.7(b), all images were combined into a montage in ImageJ
before compilation by the analysis tool. The output file, containing the spot feature
information had to be re-sliced accordingly.
Figure 5.8.: The number of dots increases upon ligand induction. HeLa cell were transfected
with CD95wt-GFP upon induction with ILZ-sCD95L and zvad, time lapse imaging
was performed. Images were segmented using the Segementation tool by Stefan
Wörz and the Matlab tool for further data processing. The number of dots on
100 µm2 of the lower plasma membrane is showed related to time.
The parameters for the smoothing, threshold, fitting size were adjusted by eye, to opti-
mize dot recognition. To avoid segmentation of big dark structures such as membrane
unevenness instead of bright dots especially at early time points where the pool of recep-
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tors is still bright, the tool was adjusted to exclude structures of size bigger than 400 nm2.
Figure 5.8 shows the number of dots per 100 µm2 appearing on the plasma membrane
over time. The dots appear steadily in time for about 90min until the dot density reaches
a plateau at about 14 to 18 dots per 100 µm2.
5.2.2. The Dot Size increases over Time
The next question was whether dots grew in size with time, so the molecules per cluster
were quantified. The integrated fluorescence intensity of one dot is directly proportional
to the number of fluorescent molecules. On the other hand the contrast of the dots is
related to the highest pixel intensity and not the number of molecules. Therefore I im-
plemented a Matlab tool to analyze histograms of the dot intensities I or contrast c for
every image. Figure 5.9 shows the distribution of values of I of one example time point
of one image. By fitting a lognormal curve to the distribution, the mean fluorescence
intensity, the mode of the curve or quantiles - like the median - can be determined for
every time point.
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Figure 5.9.: Histogram of fluorescence intensity of dots of one image at one time point. I imple-
mented a Matlab tool to determine dot intensity histograms from the dot segmen-
tation data from the analysis using the Dot Segmentation Tool of Stefan Wörz in
our department [98]. The histogram can be fit to a lognormal curve and the mean
and the mode of the distribution can be estimated from the fit.
The local background of the detected spot is not originating from noise but is fluores-
cence of the pool of soluble receptor on the plasma membrane. When receptor clusters
form, this pool is getting smaller, resulting in a decrease of this background. I tested
subtraction of this fluorescent background before spot segmentation, but the influence
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on the number of detected spots was negligible. The resulting properties such as dots
intensity and contrast were also not significantly altered, which can be explained by the
fact, that the gaussian fitting in the image processing tool results in an eﬀective local
background subtraction.
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Figure 5.10.: Histograms of dot intensity over time. The mode of the histogram, i.e. the intensity
value of the peak, increases over time.
Figure 5.10 shows the histograms of the dot intensities at diﬀerent time points. Again
at higher time points there are more dots, represented by the area under the curve. The
size of the dots also increases over time as the whole distribution shifts to the right. We
conclude that, with time, more receptor molecules get incorporated into these structures.
5.2.3. The Majority of Dots contains about seven Molecules
To related the dot formation after induction to other studies a size estimate would be
a good comparison. The SDS-stable aggregates observed in other studies in type II cell
have a typical size of 90 to 200 kDa [38], with a receptor of 45 kDa.
In microscopy the fluorescence intensity corresponds to the number of molecules, there-
fore to estimate oligomerization levels the intensity axis is calibrated.
While the contrast is measured in units, that can not be related to a biological meaning,
because it depends on pixel size and settings, the whole integrated dot intensity can
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be calibrated by comparison to characterized cells. As calibration the stable cell line
Apo-mGFP1 was imaged with the same settings, yealding an intensity of 759 /µm2. The
stable cell line has 140 000 receptors on the outside of the cell, relating to the size of
the cell membrane 2000 µm2, this results to a receptor desity of 70 /µm2 and therefore a
fluorescent intensity of 10.8 /receptor.
Using an analogous calculation the receptor concentration on the transiently transfected
cells of this experiment was estimated; the mean intensity before induction was 1227 /µm2
corresponding to a receptor concentration of 113 /µm2. The error of intensity measure-
ment (also due to uneven illumination of diﬀerent slices) was assumed to be about 8%.
Figure 5.11.: The mean and the mode of dot intensity increase over time. The calibration of
intensity axis allows for a quantification of the number of molecules per dot. Most
dots, i.e. the peak of the distribution, contain 7.2 molecules.
Figure 5.11 shows the mean and the mode of the intensity distributions over time (bars
represent the cell to cell variation estimated as standard deviations). Again it shows that
the dots grows in size over time.
With the intensity axis calibrated, one can estimate receptor numbers per dot: While
most of the dots (intensity mode) contain about 7.2 ± 3 molecules after 150min, the
mean number of receptors in the dots is about 19.8 ± 7, meaning that a few very big
dots shift the mean towards high numbers, while the majority is at 7 molecules per dot.
This calibration of intensity to receptor amount allows for an oligomerization estimate
at high expression levels. The number of molecules per dots (7.2 ± 3) is in the same oder
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of magnitude as the number of receptors observed in SDS-stable aggregates, where 90 to
200 kDa correspond to 2 to4 receptors.
The precision of measurement of clustering by detecting dots is very depending on im-
age analysis and dot segmentation. Due to the pool of unclustered fluorescent receptors,
small clusters can not be identified, as long as their intensities are still within the range of
noise and background. Therefore I studied clustering by dynamics measurement, which
can possibly allow for detection of smaller clustering, as was shown on dimerization mea-
surements of the EGF receptor. Furthermore it represents a more robust method, not
relying on the detection of single dots.
5.3. Clustering measured by Dynamics Observation
To study the formation of small clusters, that can not yet be detected as dots and perform
more robust methods for higher clustering, that are not sensitive to single dots detection,
I performent dynamics measurements of the receptor with fluorescence recovery after
photobleaching before and after induction with the ILZ-sCD95L.
5.3.1. Fluorescence Recovery after Photobleaching
In a region of interest (ROI) molecules are bleached and then the unbleached molecules
from outside the region move in, while bleached molecules move out. There are diﬀerent
methods to record and analyze these processes. One very common method is to follow
the intensity inside the ROI over time.
Recovery in the ROI
The most common FRAP- technique is to bleach an area and then follow the fluorescence
intensity in that area over time: Part of the molecules can move due to diﬀusion or other
transport mechanisms. This is the so called mobile fraction. But there might be also a
fraction of molecules fixed to structures (e.g. by attachment to the cytoskeleton or the
extracellular matrix), this is the immobile fraction. After bleaching the mobile fraction
can redistribute and its intensity in the ROI can recover, while the immobile fraction
does not recover. One example of such an intensity recovery is shown in figure 5.12
(Webpage). Axelrod et. al were first to use this technique in 1976 [99], while Soumpasis
introduced a more simple mathematical analysis in 1983 [100].
One can model this recovery assuming three diﬀerent cases:
In the easiest situation one population of molecules uses diﬀusion as only transport mech-
anism: the single component recovery. Computation of an eﬀective diﬀusion coeﬃcient
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Figure 5.12.: Example of a FRAP recovery curve
D from the recovery half time t1/2 for a circular ROI with radius ω is relatively straight
forward [100]:
D = 0.224
ω2
t1/2
(5.1)
In a more complex situation one has to consider multiple components for the diﬀusion
equation, e.g. binding and release from intracellular components or monomeric and mul-
timeric forms. In the third case alternative movement mechanisms might occur such as
molecular motors or membrane tension flow.
However this method of diﬀusion coeﬃcient estimation has its limitations: on the one
hand it is highly dependent on a correct estimate of the size of the ROI ω, additionally it
is assuming that the bleaching takes place in a much shorter time than the recovery, but
experimentally bleaching is performed with a scanning laser with finite remaining times.
During the bleaching process therefore molecules can diﬀuse leading to a smearing out of
the bleaching profile, a corona eﬀect. Weiss [101] performed simulations of these eﬀects
and found that the normal experimental procedure can lead to an underestimation of the
diﬀusion coeﬃcient up to 4-fold.
In this work, diﬀusion coeﬃcients will be measured on the lower plasma membrane of
adherent cells, therefore these problems can be circumvented by the analysis of bleaching
profiles in space.
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Recovery of bleaching profile
There have been various theoretical considerations on the influence of the bleached pat-
tern of FRAP analysis [102]. One experimental example using the analysis of the bleach-
ing profile instead of the recovery half time t1/2 was performed in 1986 on a macroscopic
scale to measure diﬀusion (and convection) of tissue fluid where a point wise digitization
of the image was used for recording and later fitting of the bleaching profiles [96].
In our experiment on the relatively flat, lower plasma membrane of the cell we used the
technique to bleach a stripe and observe the progression of the bleaching profile over
time [103] ([96] [102]). The bleached molecules diﬀuse out of the stripe and fluorescent
molecules diﬀuse into the stripe, making the stripe larger and dimmer. The intensity
profile I(x) can be approached by a Gaussian function in space x of the width σ:
I(x) =
c0
σ
√
2π
exp
￿−x2
2σ2
￿
(5.2)
As shown in chapter A.1 the width of this Gaussian is proportional to time t, with the
slope related to the diﬀusion coeﬃcient D.
σ2 = 2Dt (5.3)
The advantage of this method is, that it does not depend on the assumption of fast
bleaching and the precise estimate of the bleaching profile for time point 0. Instead time
point 0 has no meaning and the fitting of the slope yields an accurate estimation of the
diﬀusion coeﬃcient as long as the profiles themselves can be fit well to gaussian curves.
Experimental procedure
To determine the diﬀusion coeﬃcient of the transmembrane protein CD95-GFP, we chose
cells with a flat lower plasma membrane and bleached a stripe of about 2 µm. Gradually
the bleached molecules diﬀuse out of the stripe and fluorescent molecules diﬀuse into the
stripe, making the stripe larger and dimmer. For expected diﬀusion coeﬃcients in the
range of 0.1 µm2, it means 100 s to cross half the stripe.
As illustrated before, the settings for the bleaching should aim for fast bleaching at high
laser power. For the imaging, setting needs to be optimized for the competing quantities.
There is a tradeoﬀ between time resolution for an optimal fitting of the equation 5.3,
space resolution for the profiles and minimal laser power to avoid corruption by bleaching
while imaging.
Therefore pixel size was not chosen to highest spatial resolution, but set to 247 nm. At
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Figure 5.13.: Example of a recovery of a bleached stripeon the lower plasma membrane. HeLa
CD95-knockdown cells were transiently transfected with CD95-wt-mGFP. After
three to four days the lower plasma membrane was imaged, following the FRAP
bleaching protocol. Upper left: lower plasma membrane before bleaching. Upper
middle: bleaching of a stripe. Upper right: bleaching profile directly after bleach-
ing. Bottom: recovery and widening of bleaching profile with time. Scale bar
5 µm
optimal PMT and Laser-settings, this leads to one image every 0.28 s, while still having a
signal to noise ratio of 29/12 (Intensity in arbitrary units), that allows for a good fitting
2 µm-profile. We tested bleaching at high laser power and with these settings 20 scans
lead to a high bleaching while still being relatively fast.
One FRAP-measurement is performed as following: with the settings from above 20 im-
ages are acquired directly before bleaching. Then a ROI is bleached with 20 scans at
highest laser power and following directly 100 images were acquired to follow the recov-
ery of the bleached area. Examples of a cell before bleaching (1), during bleaching (2)
and recovery between 0 s (3) and 10 s (6) after bleaching are displayed in 5.13. At the
early time points (3) the bleaching stripe is dark and narrow, at late time points (6) the
bleaching recovered to a nearly even distribution.
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Figure 5.14.: The diﬀusion coeﬃcient D is estimated by observing bleaching profile recovery.
The profile is fit to a gaussian of width σ for every time point, based on a Matlab
Tool by Clarissa Liesche in our department. According to equation 5.3 the width
of the profile is proportional to the time and D. The latter is estimated by a linear
fit as shown in Figure 5.15.
The mean profile of the stripe for every time point t is calculated from the images in
ImageJ (automated with a plugin from Joël Beaudouin) after background subtraction
and normalization with the intensity before bleaching.
These profiles are fit to a gaussian of width σ. Clarissa Liesche provided a Matlab-tool
for automated fitting of these curves to the gaussian function, equation 5.2. Figure 5.14
shows the bleaching profiles (raw data on the left) and the respective fits (right) of one
example cell for one FRAP measurement (= 100 profiles).
When plotting the width σ against the time, one can fit the linear relationship, Figure
5.15 and estimate the diﬀusion coeﬃcient according to equation 5.3. Since the profile is
becoming more and more shallow, the error of the fit also increases with time, therefore
by means of the error it has to be decided until which time point profile data are used
for the later linear fit. To guarantee comparability of diﬀerent data sets, we decided to
fit until 30 time points corresponding to 8.4 s.
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Figure 5.15.: The diﬀusion coeﬃcient is estimated from linear fit of the width of the bleaching
profiles estimated in Figure 5.14 to time, according to equation 5.3.
5.3.2. CD95 diﬀuses three to four-fold slower upon Induction
To test whether the receptor oligomerizes after induction, we measured a time series
of FRAP after induction. In an automated measurement the same cells were imaged
with the above described FRAP-protocol at diﬀerent time points after induction with
ILZ-sCD95L. Again, in order to image receptor on the membrane and not in internal
traﬃcking pathways, cells were imaged three to four days after transfection and plated
on fibronection-coated glass. (data acquisition: Verena Rickert, internship in our depart-
ment)
Figure 5.16 shows the results of the diﬀusion coeﬃcient measurement. There is a clear
slowdown of the receptor with time, leading to a 3 to 4-fold lower diﬀusion coeﬃcient
after 40min for CD95wt. The diﬀusion coeﬃcient before induction is 0.158 µm2/s, cor-
responding very well to literature data for other transmembrane proteins at 37 ◦C ([94])
- ranging between 0.03 µm2/s and 0.3 µm2/s depending on cell type and protein.
5.3.3. Possible Slowdown Reasons
It is not straight forward to interpret this drop in diﬀusion coeﬃcient for CD95wt-GFP,
since there are various reasons that can lead to a real or apparent decrease, as also dis-
cussed in 2.3.1 and 5.3.1:
One possibility is that diﬀusion is slowed down by a clustering of the diﬀusing molecules.
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Figure 5.16.: Fluorescence recovery after photobleaching shows a slowdown of the receptor after
induction with ILZ-sCD95L. HeLa CD95 knockdown cells were transiently trans-
fected with CD95wt-mGFP. Three to four days after transfection cells were induced
with ILZ-sCD95L and the diﬀusion coeﬃcient was measured using stripe bleaching
fluorescence recovery. Measurements were automized as a time series to increase
precision thus allowing for a comparison between time points. The error bar rep-
resent the cell to cell variation. (data acquisition: Verena Rickert, internship in
our department)
The increase in membrane spanning radius would slow down the proteins. As discussed
before a quantitative description depends on the exact protein and protein interaction
structure, that we can only estimate for CD95, therefore clustering can only be observed
qualitatively and not quantitatively by FRAP.
A second possibility to account for an apparent slowdown is the directed movement of
CD95 either into one direction on the plasma membrane or out of the membrane by
endocytosis. The latter was excluded in chapter 5.1, which indicates that dots are not
mainly endosomes. Figure 5.17 shows that the mean of the gaussian profile does not
move in space, excluding a directed flow of receptors.
A third possibility to slowdown transmembrane receptors is the transient interaction with
or binding to other cellular components, again including many possibilities: the redis-
tribution into lipid raft and attachment to the cytoskeleton are examined in ??. Also
binding of molecules of the DISC intuitively is a possible explanation for a slowdown of
the receptor. However it has been shown, that due to the high viscosity of the plasma
membrane, the transmembrane domain is the main diﬀusion determining part of a trans-
membrane protein [84], while protein domains and binding particles in the aqueous phase
do not slowdown significantly (e.g. domain deletion on the EGF-receptor [104] or binding
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Figure 5.17.: The estimation of diﬀusion coeﬃcient by FRAP can be faulted by a directed flow
of the measured molecules. In the experiment of Figure 5.16 the center of the
bleaching profile, estimated by the gaussian fit, did not move in space excluding
the possibility of a directed flow.
of quantum dots [105] does not change the diﬀusion coeﬃcient).
A fourth possibility, that could account for the lower diﬀusion coeﬃcient is, that confor-
mational changes through induction increase friction and thus slow down the molecule.
With little information on the structure of CD95 as there is, it is diﬃcult to exclude this
possibility, however a slowdown of 3 to 4-fold as observed in the experiments is rather
unlikely to be originated only in a small conformational change.
Fluorescence recovery after photobleaching of the receptor showed a three to four-fold
slowdown of the receptor about one hour after ILZ-sCD95L induction. The upper reason-
ings propose clustering of the receptor as most likely reason for the measured slowdown.
This clustering measurement is consistent with the clustering observed via dots formation
analysis in chapter 5.1. FRAP receptor slowdown measurements confirm the observed
clustering and show similar time scales of cluster formation and of cluster saturation.
Both methods, the dots formation analysis and the dynamics measurements were used
to investigate the origin of clusting and possible clustering mechanisms.
5.4. The Only Aggregation Mechanism is Crosslinking by
the Ligand
In chapter 1.3 the diﬀerent signaling regulation mechanisms were described, that can
lead to receptors clustering at diﬀerent levels. To test whether dot-formation is related
to these mechanisms, diﬀerent mutants were analyzed in terms of dot formation. The
focus was put especially on death domain clustering and lipid rafts.
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5.4.1. The Receptor Aggregation is independent of the Lipid Rafts
Feig et al. studied in detail the SDS-stable aggregates containing CD95 receptor, that
form as early signaling events in type I cells followed by actin-dependent internaliza-
tion. In SKW 6.4 and H9 cells they could show, that formation of these aggregates in a
palmitoylation- dependent process and the formation is abrogated when palmitoylation
is blocked by mutation of cysteine 199, reducing internalization and caspase 8 activation.
The same palmytoylation site has been reported to responsible for the localization of
CD95 to actin cytoskeleton-linked rafts upon stimulation in Hek293T cells [42]. (Both
publications show the necessity of palmitoylation of cysteine 199 for CD95 internalization
and eﬃcient signaling.)
The dots observed in HeLa type I cells in Figure 5.5 have similar size as the SDS-stable
aggregates, for a further comparison the functioning upon palmitoylation inhibition was
tested. To test whether formation of the dots is palmitoylation dependent, the CD95-
C199V mutant was imaged at the same conditions as experiments above upon ILZ-
sCD95L induction. The palmitoylation mutant formed similar dots as the wt-receptor,
Figure 5.18. In the majority of clusters (mode of intensity) there are 9.2 ± 3 molecules
(where 3 indicated the cell to cell variation), which is the similar dot size as for the wt
receptor. Quantification does not show significant diﬀerence between dots formation of
the palmitoylation mutant and dots formation of the wt receptor.
Figure 5.18.: Dot formation is not palmitoylation dependent. HeLa CD95-knockdown cells were
transiently transfected with CD95-C199V-mGFP, imaged and analyzed as before.
Scale bar: 5 µm
79
5. CD95-Clustering at High Expression Levels
This shows that contrary to the studies in type II cells, the formation of dots that can be
observed by microscopy is not palmitoylation dependent. (As observed in other exper-
iments (data not shown), cells transfected still very eﬃciently went to 100% apoptosis,
the endogenous receptor in the knockdown cell lines contributes only to 10% cell death
as shown in chapter 3.1).
To confirm that palmitoylation is not the reason for clustering using a more robust
method, dynamics measurements of the CD95-C199V mutant were performed in the
same conditions as for the wild type receptor.
Figure 5.19.: Receptor slowdown is not palmitoylation dependent. HeLa CD95-knockdown cells
were transiently transfected with CD95-C199V-mGFP. FRAP diﬀusion coeﬃcient
measurements were performed before and after indcution with ILZ-sCD95L in an
automated time lapse experiment. Error bar represents the cell to cell variation.
(data acquisition: Verena Rickert, internship in our department)
Before induction (time point 0 in 5.19 ) the construct diﬀuses at the same speed as the
wild type receptor, (data acquisition: Verena Rickert, internship in our department),
showing that mutation itself does not influence receptor diﬀusion. Upon induction with
ILZ-sCD95L the construct shows the same 3 to 4-fold slowdown as the wild type recep-
tor. Therefore lipid rafts can be excluded as reason both for slowdown and for clustering.
The observed clustering in both the dot formation and dynamics experiments is not due
to palmitoylation of cysteine 199. Therefore the observed aggregates do not correspond
exactly to the SDS-stable aggregates found in type I cells, since they are still able to form,
when palmitoylation is inhibited. The cysteine 199 has been shown to be the targeting
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signal for the lipid rafts and in Hek293T cells is the connection to the ezrin-mediated
cytoskeleton association, which is necessary for the subsequent internalization. Figures
5.18 and 5.19 however show that in HeLa dot formation and clustering is independent of
this raft targeting and the ezrin-mediated cytoskeleton association.
5.4.2. The Receptor Aggregation is independent of the Death Domains
The observed dots in HeLa cells of type II do not directly correspond to the SDS-stable
aggregates observed in type II cells and do not form in the same palmitoylation depen-
dent manner. There has been another observation of CD95 aggregates: the so-called
SPOTS (signaling protein oligomerization transduction structure) can be observed di-
rectly by microscopy as spots on the cells after induction. Both the CD95 death domain
and FADD are independent for the formation of these aggregates in Jurkat cells as well
as CD95-mediated cell death [37]. The central role of death domains for clustering are
also supported by structural studies as was discussed in chapter 1.3.
To test whether the observed dots in HeLa form via death domain clustering of the
receptor, we imaged the construct, where the death domain was deleted, CD95-∆(210-
233)-mGFP, as before with time-lapse microscopy after ligand induction.
Figure 5.20.: Dot formation is not caused by the CD95 death domain. HeLa CD95-knockdown
cells were transiently transfected with CD95-∆(210-233)-mGFP, imaged and ana-
lyzed as before. Scale bar: 5µm.
The death domain deletion did not disturb dot formation. Dots form at the same time
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scale and size was even slightly higher (this will be discussed further in the next chapter):
9.7 ± 4 molecules per cluster (mode of intensity), Figure 5.20. (The deletion of the death
domain as expected inhibited CD95-mediated cell death (data not shown)).
To confirm this finding, that clustering is death domain independent, FRAP dynamics
measurement of the mutant lacking the death domain, CD95-∆(210-233)-mGFP, were
performed.
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Figure 5.21.: Receptor slowdown is not death domain dependent. Fluorescent recovery after pho-
tobleaching measurements on a mutant lacking the death domain, CD95-∆(210-
233)-mGFP, confirm that the receptor clustering at high expression levels is death
domain independent. HeLa CD95 knockdown cells were transfected with CD95-
∆(210-233)-mGFP and the diﬀusion coeﬃcient measured in an automized manner
as a function of time as described before, Figure 5.16. (data acquisition: Joël
Beaudouin in the department)
The mutant showed same decrease in diﬀusion coeﬃcient up to three to four-fold after
induction with ILZ-sCD95L. The experiment was performed with a 10 times dilution of
the ILZ-sCD95L, which explains the longer time scale of dot formation. To confirm, that
dot formation is on the same scale, experiments should be repeated with same ligand
concentrations as used in the wild tipe.
The dynamics and dotsformation experiments show, that the observed aggregation of
CD95 receptor in HeLa is not due to a clustering via the death domain. The mutant
lacking the death domain is slowed down after ligand induction to the same extent as
the wild time receptor and dots formation takes place at a similar time scale and extent
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as for the wild type receptor. Contrary to SPOTS formation in Jurkat cells, the death
domain is not required for the clustering of the receptor in HeLa cells observed by dot
formation analysis and dynamics measurements.
5.4.3. The Dot Size is Concentration Dependent
The fact, that cluster sizes vary slightly raised the speculation, that cluster size depends
on expression levels. Since cells were transiently transfected, expression levels vary from
cell to cell, making it possible to measure cluster size as a function of initial concentra-
tion. To test the concentration dependence, cluster size at 150min was plotted against
receptor concentration before induction, calibrated as shown before in chapter 5.2.3. Be-
cause of its intrinsic inhibition of apoptosis the death domain deleted mutant can be
expressed at higher expression levels than the functional constructs.
Figure 5.22.: The dot size depends on the initial receptor concentration.
The cluster size increases with initial concentration but seems to reach a plateau at a
concentration of 200 receptors per µm2. The aggregate formation in HeLa cells is con-
centration dependent. This is complemented by measurement of surface expression levels
in CD95 knockdown clones, in which the receptor concentration is proportional to per-
centage of cell death, chapter 3.1.
In the experiments of this chapter, I observed formation of dynamic clusters of the CD95
receptor after ILZ-sCD95L induction in type I HeLa cells. The clusters were quantita-
tively analyzed by image analysis and cluster size was estimated to 7 ± 3 molecules per
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dot (for the majority of dots, i.e. the intensity mode). Dynamics measurements showed a
slowdown of the receptor after induction, that confirmed the cluster formation observed
by dot formation analysis.
The mechanism of clustering and dot formation can be neither related to lipid raft lo-
calization via the palmitoylation of cysteine 199, not can it be contributed to the CD95
death domain clustering. This indicates that the observed clusters are another kind of
structure than the reported SDS-stable aggregates or the so-called SPOTS observed by
microscopy in type I cells.
The mechanisms lipid raft localization and death domain clustering were exclude, which
also excludes further downstream events such as FADD recruitment as clustering reason.
Therefore the ligand induction itself appears as a very strong mechanism, that at high
receptor concentrations already alone induces a formation of large aggregates.
Since dot size of receptor clusters as well as the death inducing eﬀect of the receptor
is concentration dependent, cluster formation at physiological expression levels in HeLa
cells could give more insight on the possible function or necessity of cluster formation for
apoptosis induction.
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6.1. The CD95 Organization on the Plasma Membrane at
Confocal Resolution
To observe the CD95-receptor distribution on the plasma membrane, we stained the cells
by immunofluorescence and imaged 3D-stacks with Confocal Laser Scanning Microscopy
(CLSM). At the highest resolution of CLS-microscopy the receptor distribution appears
as a dotty pattern, Figure 6.1. To observe only receptors located on the plasma membrane
and not those in the cytosol, the cells were not permeabilized. The cross-sections in the
figure show clearly, that no staining is inside the cell.
Figure 6.1.: 3D-Image of the whole cell. The figure shows only four out of about 60 cross sections
of the cell. Top: the whole cell at low magnification. Bottom: the ROI marked in
top at 3-fold higher magnification. Scale bar 10µm.
To prove that this pattern is not an artifact of the fixation and immunostaining, we
imaged a stable clone, that expresses the fusion protein CD95-GFP at physiological ex-
pression levels in living cells. At these relatively low concentrations these fluorescent
molecules are too dim to be well distinguished from the autofluorescence background,
86
6. CD95-Clustering at Physiological Expression Levels
so that they can not be resolved with normal confocal microscopy. To avoid the cy-
tosolic background I performed total internal reflection fluorescence (TIRF) microscopy
(in collaboration with Michael Schwering). In this technique, the evanescent filed only
illuminated a 100 nm-thick layer near the glass, that includes the plasma membrane,
while the cytosol is not illuminated and therefore does not generate background. In or-
der to image life cells relatively high laser powers and short illumination times were used.
Figure 6.2.: Life cell imaging of receptor distribution shows the same dotty pattern: HeLa sta-
bly expressing CD95-GFP at physiological concentrations were imaged with total
internal reflection microscopy (collaboration Michael Schwering) to reduce autoflu-
orescence background. Scale bar 5µm.
The receptor distribution at the lower plasma membrane of the CD95-GFP clone, shows
the same dotty pattern, Figure 6.2, as the immunostained 3D-stacks of HeLa cells. There-
fore I conclude, that the optimized fixation and staining protocol enables the imaging of
the receptor distribution on the plasma membrane, as it appears in living cells.
For physiological expression levels the receptor distribution can be resolved and shows
single dots. But what are these dots? Are these single monomeric receptors or clusters
of receptors?
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6.1.1. Quantification of Dots
based on Dot Segmentation Tool by Stefan Wörz [98]
In order to relate to the amount of clustering or oligomerization, I quantified the dots on
the plasma membrane of stacks of whole cells and related to the amount of receptors on
single cells as determined in chapter 4.1.2.
The Dot Segmentation Tool by Stefan Wörz described in chapter 3.8 and in [98] was used
to segment the dots in this dotty pattern and determine number of dots per cell. Figure
6.3 shows a segmentation example, where segmented dots are marked with a black point.
Figure 6.3.: Example for dot segmentation with Dot Segmentation Tool by Stefan Wörz [98].
The segmented dots are marked with a black points, the big black points mark
dots centered in the image plain, the small black points mark the dots centered in
another plain of the 3D image. Scale bar 10µm.
The number of dots in tryout analysis displayed itself very sensitive to the various tunable
parameters and could vary largely even when the visual impression was the same. This
is due noise, that is wrongly segmented as dots. To understand this high variance due to
noise, I analyzed the number of dots Ndots(ω, f) as a function of those parameters, that
it appeared most sensitive to: the smoothing factor ω and the threshold factor f , Figure
6.4.
When the smoothing kernel is chosen small (= small ω), the noise is not filtered out cor-
rectly and segmented as dots. When ω is chosen too big, also the signal of smaller dots
will be smoothed, so that these dots are not segmented. Typical values for smoothing
would be around the resolution of the microscope (here corresponds to ω = 1), taking
account for the fact, that any peak of width smaller than the resolution can only be
noise.
Similar considerations hold true for the threshold factor f : if chosen too high, not all
dots are segmented, when chosen too low, noise will be considered as signal. Since the
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Figure 6.4.: Analysis Optimization. The number of segmented dots estimated by the Dot Seg-
mentation Tool of Stefan Wörz [98] highly depends on the choice of adaptable
parameters. To optimize the dot segmentation I studied the the number of seg-
mented dots as a function of the parameters ω and f . When the parameters are
chosen high, a lot of signal is excluded and not segmented as dots, resulting in an
underestimation of number of dots. When parameters are chosen too low, noise is
segmented as dots, leading to an overestimation of dots. Therefore I concluded that
noise plays an eminent role when analyzing images using the Tool and so I aimed
for reduction of noise and subsequent optimal parameter choice using histograms,
Figure 6.5.
threshold is defined by T = µh + fσh (where σh and µh are center and width of the
noise distribution histogram) a factor around 1 should exclude most of the noise, while
including as much signal as possible.
To avoid segmentation of noise, I looked for criteria, that allow for distinction of seg-
mented noise and real dots, since the visual impression was not as accurately as needed
(many dots at high concentration confuse the eye). To find this criterium, I plotted the
properties of the single dots obtained from the segmentation as histograms. Figure 6.5
(a) shows an example of these frequencies of dot intensities idot, the dot size sdot and the
contrast cdot. In this example only the parameter f was varied. The histograms show
that the variation in number of dots mostly derives from dots of low intensity or contrast,
confirming the fact, that noise is wrongly segmented and corrupts the measurement of
dots.
89
6. CD95-Clustering at Physiological Expression Levels
0 2 4 6 8 10
x 104
0
20
40
60
80
100
Integrated dot intensity (AU)
0 5 10 15 20 25
0
20
40
60
80
100
Fr
eq
ue
nc
y
Dot Size
 
 Threshold factor0.5
1.0
1.5
2.0
0 0.5 1 1.5 2
x 104
0
50
100
150
Contrast (AU)
(a) whole image
0 2 4 6 8 10
x 104
0
20
40
60
80
100
Integrated dot intensity (AU)
 
 
Cropped: f=2
Cropped: f=1
0 5 10 15 20 25
0
20
40
60
80
100
Fr
eq
ue
nc
y
Dot Size
 
 Threshold factor0.5
1.0
1.5
2.0
0 0.5 1 1.5 2
x 104
0
50
100
150
Contrast (AU)
(b) cropped image
Figure 6.5.: Analysis Optimization: One example of frequency histograms of dot integrated
intensity idot, size sdot and contrast cdot for variation of the parameter f . Similar
histograms can be obtained for variation of ω. (a) When the analysis parameter is
varied the number varies for those dots with low intensities, size and contrast, i.e.
for the noise. (b) A lot of noise can be excluded by cropping the image to cell size
before analysis.
One of the major improvement is the cropping of the image to the size of the cell, thus ex-
cluding a lot of noise and background from the glass next to the cell. Figure 6.5 displays
the histograms of an uncropped image that show, that much more noise was segmented
as dots. Especially for low intensities and low contrast a lot of noise is raising the fre-
quency values in the histogram compared to the cropped image (black line). Therefore
all images were cropped before further analysis.
In order to exclude the noise from the number of segmented dots, the intensity histogram
was fit to a lognormal distribution f(idot), Figure 6.6, and the area under the curve
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Figure 6.6.: Analysis Optimization: The dot integrated intensity histogram , generated by a
Matlab tool, can be fit to a lognormal distribution. Integration of this fit will yield
a more reliable estimate of the number of dots than simple counting, because it
excludes noise.
estimated that corresponds to the number of segmented dots.
Ndot =
￿
f(idot) di (6.1)
By fitting the noise is excluded. It is not sensible to fit the dot size sdot or contrast cdot,
because the former is determined by a combination of the point spread function of the
microscope and biological reasonings. Also the latter is not a measure of a real biological
quantity and thus not as suited as the integrated intensity.
The histogram and its fit constitute an optimal criterium for the parameter choice. Figure
6.6 and 6.5 refer to f = 1 as optimal, including little noise but maximun signal. Similar
histograms for ω indicate 0.6 as a good choice. Therefore in the following cells were
analyzed with parameters ω = 0.6 and f = 1.0.
6.1.2. The Number of Dots is Proportional to the Cell Size
By implementing a Matlab analysis of the dot intensity histograms, I have established a
tool to optimize the segmentation data from the Dot Segmentation Tool of Stefan Wörz
[98] for these specific immunofluorescence images to determine a precise estimate of the
number of dots per cell. Using this optimized tool I determined the number of dots on
thirty cells of three replicate samples, Figure 6.7.
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Figure 6.7.: The number of dots per cell Ndot is proportional to cell size Scell: HeLa cells were
fixed and CD95 was immunostained with Apo1-3 mouse and anti-mouse Alexa488
antibody. The number of dots was estimated with the Dot Segmentation Tool by
Stefan Wörz [98] using the before optimized parameters: f = 1 and ω = 0.6.
My first observation was, that the number of dots on the cells Ndot is proportional to cells
size Scell. Cell size here was measured as the projection of the cell on the x-y plane, a
good estimate also of the cell volume, because the cells are very flat on the glass. Cell size
was estimated automatically by setting a threshold on fluorescent images after checking
that this estimate corresponds to an cell size estimate by hand.
Ndot = 2.7Scell + 550 (6.2)
Furthermore the cell size and thus also the number of dots per cell is lognormal dis-
tributed, Figure 6.9 , just like the number of receptors per cell, chapter 4.1.2.
For this number of cells the median can only be estimated inaccuratly, demonstrated by
the diﬀerence between median estimate from data ￿Ndots￿ = 4090 and estimate from the
lognormal fit ￿Ndots￿ = 3647.
6.1.3. The Mean Number of Dots per Cell is 4300
To obtain a better estimate for the median number of dots per cell, I used the propor-
tionality: instead of estimating the median from the distribution of number of dots from
30 cells, I estimated it indirectly from the size distribution.
At low magnification and resolution it is easy to acquire big fields of view with hundreds
of cells, where the size is automatically analyzed in ImageJ. With a sample number
of 600 cells the distribution is more accurately defined, Figure 6.9, and the median cell
size estimated from the data corresponds to the median estimated from the lognormal fit.
Using equation 6.2 the mean number of dots per cells was estimated to ￿Ndots￿ = 4300.
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Figure 6.8.: HeLa cells were immunostained for the CD95 receptor and segmented using the Dot
Segmentation Tool by Stefan Wörz [98]. The number of dots per cell Ndot and cell
size Scell are lognormal distributed. For this relatively small number of cells, the
median can only estimated with a relatively high error, showing in the diﬀerence
between median estimation from the data directly and median estimation from the
lognormal fit.
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Figure 6.9.: More accurate estimate with higher sample size: 600 HeLa cells were immunostained
and imaged at low magnification with a large field of view to obtain a high sample
number and size was estimated automatically with ImageJ. The histogram allows
for a precise estimate of the mean cells size: 1381 µm2, relating to a mean number
of dots Ndots = 4300.
This number can be directly compared to the number of receptors per cell, measured in
chapter 4.1.2, since for both measurements exactly the same staining procedure was used.
However the number of dots is not yet easy to interpret, because resolution and noise of
the microscope will temper with the signal, that not every dot can be seen. Therefore
relation between dot number and receptor number will be further discussed and analyzed
with a simulation in chapter 6.2.
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6.1.4. The Intensity Calibration reveals that most Dots contain less than
Three Receptors
There are several ways to estimate the oligomerization state of the receptors on the
plasma membrane from the images shown above. While the comparison of dot number
and receptor number is discussed in detail later, here I want to take a side trip on what
can be learned from the intensities themselves. The intensities of the dots idot can be
summed up over the whole cell to estimate the cells intensity Icell. However because of
the cell to cell variation this should not yet be related to the receptor number but rather
averaged over the number of cells to estimate a mean cell intensity:
￿Icell￿ =
￿
Ncells
Icell
Ncells
=
￿
Ncells
￿
f(idot) di
Ncells
(6.3)
This mean cell intensity is exactly the same quantity that was measured in chapter 4.1.2
and corresponds to the measured 20000 receptors per cell.
￿Icell￿ ⇔ 20000 receptors irec ⇔ ￿Icell￿20000 (6.4)
The receptor intensity in the microscopy images therefore is irec = 13600 (arbitrary units)
so that the intensity scale can be calibrated.
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Figure 6.10.: HeLa cells were immunostained for CD95, the dotty pattern imaged and analysed
(Dot Segmentation Tool by Stefan Wörz [98]) and the intensity histogram gen-
erated. Averaging the intensity over 30 randomly chosen cells (only 10 displayed
for clarity) allows for a calibration of the intensity axis to single receptor intensity
irec. The median dot intensity is about 1 · irec. This indicates that receptors are
not massively clustered at the plasma membrane but rather distributed at low
oligomerization level.
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Figure 6.11 plots the dot intensity distributions f(idot) for 30 diﬀerent cells (only 10
shown for clarity). The median dot intensity idot for most cells is about or below the
intensity for one receptor irec.
However a multilevel antibody staining is used, where not every receptor has the same
amount of fluorescent dyes. Therefore the dot intensity distribution could origin from
a diﬀerent amount of receptors per dot, but also from a diﬀerent amount of fluorescent
dyes, which can explain dot intensities below the intensity of one receptor.
Furthermore, we do not yet know, whether dots originate from physical clustering of
receptors or from randomly near receptors, that by broadening through the point spread
function appear as one dot.
The intensity calibration shows, that receptors are not massively clustered on the plasma
membrane. If receptors form clusters, the dots do not necessarily correspond to clusters,
however they constitute an upper limit for the number of receptors per cluster. The
calibrated histogram of dots therefore gives a first indication, that if the receptors form
clusters, these are very small (2 to 10 receptors) and the peak of the distribution at 1
indicates that a significant part of receptors will still be monomeric.
6.1.5. The Lower Membrane represents the Whole Cell
To check that staining is also complete on the lower part of the cell and antibodies can
enter the space between membrane and glass, I analyzed only the lower part of the plasma
membrane and compared to the whole cell analysis.
The analysis of only the plasma membrane for the upper cells yields a number of 211±13
dots per 100 µm2.
The size of the plasma membrane of whole cells was estimated by microscopy of cells,
that were detached and slighly swollen by osmotic pressure, so there were no folds in
the plasma membrane. The mean cell surface size is 2000 µm2. Therefore the whole cell
analysis adds up to 215 dots per 100 µm2.
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Figure 6.11.: Outline of cell position on the glass. The lower plasma membrane lyes flat and
does not fold massively, while the upper membrane folds into so called filipodia.
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The analysis of the lower plasma membrane is in very good agreement with the whole
cell analysis, confirming the fact, that the lower plasma membrane is well stained and
opening the possibility to only analyze the lower plasma membrane, as will be used for
high resolution microscopy in chapter 6.3.
6.2. Simulation of the Microscope Characteristics
There are less dots in the images than the receptor density implies. This fact is not easy
to interpret. It could be due to a clustering or oligomerization of the receptors, but it
could also be that receptors are randomly near to each other and due to resolution width
merge to one dot in the image. Additionally the fluorescence of staining is diﬀering and
noise is covering part of the signal. Therefore we simulated the diﬀerent scenarios: ran-
domly distributed monomers or oligomers/clusters. Simulations include the microscopy
resolution, background, noise and fluorescence distribution. There are a number of in-
put parameters for the simulation, that were estimated from the experimental data as
described in the following. Then a workflow for the generation of in silico images was
established using these parameters.
Input Parameters for the Simulation
The receptor concentration in physiological expression on HeLa cells was estimated in
chapter 4.1.2 to 10 receptors per µm2.
The median fluorescence of one receptor ￿F ￿ = 2000 (arbitrary units) was at first
roughly estimated single lying dots in the experimental images and refined later,
since a priori it is not known, whether single dots correspond to single receptors.
The antibody fluorescence distribution is caused by the multilevel staining with pri-
mary and secondary antibody, leading to diﬀerent amounts of fluorophores on
diﬀerent receptors. We determined the fluorescence distribution of the staining
measuring primary and secondary antibody, that were bound to glas (Figure 6.12).
It is lognormal (equation 6.5) with µ = 5.26 and σ = 0.93. The normalization fac-
tor N relates to intensities of this particular measurement and is not comparable
to experiments in cells.
F = N ∗
￿
exp
−(µ2 + log x)
2σ2
￿
/
￿
2πxµ (6.5)
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Figure 6.12.: Fluorescence distribution of the antibody staining. Apo1-3 mouse antibody was
absorbed to glass surface, blocked and then stained with anti-mouse-Alexa488
antibody. The antibodies were imaged and images segmented and evaluated as in
chapter 6.1 to obtain the intensity histogram.
The spatial resolution was determined on single lying dots in the experimental images
and adds up to 230±12 nm.
The background intensity and noise was determined on not stained ROIs inside the
cells and fit to a gaussian distribution with mean µh and width σh.
Workflow of the Simulation
Receptor coordinates and fluorescence intensities: I simulated 1000 receptors in three
dimensions for an area of 100 µm2. Coordinates were generated with a random
number generator for every receptor, for the case of oligomers coordinates for the
first receptor were randomly generated and set to the same value for the other
receptors of the oligomer. The fluorescence value for every receptor was also ran-
domly generated, but here a special plugin had to be used, so that fluorescence
values follow the experimentally determined lognormal distribution values < F >,
σ and µ, that were determined before.
Broadening with point spread function: the fluorescence intensity distribution was con-
voluted with the point spread function of the microscope to account for the mea-
sured spatial resolution.
Pixelization: the intensity distribution was binned into pixels in order to optain a 16bit-
3D-image of size 100 µm2 x 1.5 µm and pixel size 83 nm x 83 nm).
Noise and background generation: background and random noise, following a normal
distribution with σh and µh as determined from the experiment, were added to
every pixel of the image
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Figure 6.13.: Generation of in silico images: Step 1: generate receptors with coordinates and
fluorescence intensity that follow the lognormal distribution. Step 2: Convolve
with the points spread function. Step 3: pixelize to a 16bit image of pixel size
83 nm. Step 4: add noise and background according to experimental distribution.
Step 5: iteratevely re-adjust receptor intensities ￿F ￿ to yield the experimental dot
intensity idot(exp)
Adjusting fluorescence intensities: as discussed before the median fluorescence ￿F ￿ of
single receptors can not be determined from the experimental images directly and
therefore was approximated before. In this last step this input value was adjusted
in an iterative process by comparing the brightness of dots idot(sim) (output value)
of the simulations to the experimental images idot(exp).
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6.2.1. In Silico Images
Using this workflow, in silico images for the three diﬀerent scenarios were generated: the
receptor being monomeric, dimeric or trimeric, Figure 6.14.
(a) In silico monomer (b) In silico dimer (c) In silico trimer
Figure 6.14.: In silico images for each of the three scenarios. Following the workflow represented
in Figure 6.13 for every scenario 20 images of size 100µm2 were generated with
the experimentally deterimined resolution 230 nm. Scale bar: 5µm
To test variation from randomness, 20 images were generated for every scenario, that
from the visual impression are all similar to the shown examples in the Figure. In the
following error bar will indicated this variation due to randomness.
6.2.2. Many Oligomers contain less than Three Receptors
The reason for simulation was to test whether the low number of dots, compared to
number of receptors is due to a clustering of the receptors or whether the random dis-
tribution pared with resolution and noise leads to a visual merging of receptors that are
not actually clustered. Therefore a criterium to compare simulation and experimental
images is needed since the visual impression here might not be reliable.
Hence I chose the number of segmented dots using the Dot Segmentation Tool of Stefan
Wörz [98] as criterium for comparison of the simulation to the experiments, Figure 6.15.
To estimate the suitability of this quantity for a comparison I considered the possible
sources of error.
One possible source of error is the sensitivity of the Dot Segmentation Tool of Stefan
Wörz [98] to the adaptable analysis parameters, as was discussed in chapter 6.1. However
this error source was excluded by exactly modeling all image properties such as noise,
background, resolution to best approximate the experimental images. Therefore in silico
images are analyzed with exactly the same analysis parameters as the experiment to
exclude this source of error.
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A second possible source of error is the image resolution. As described earlier the reso-
lution is one of the main reasons, that could lead to a merging of receptors in the image
that in reality are seperate. The resolution, i.e. the width of the point spread function,
was measured on the experimental image and is 230±12 nm.
To test the error arising from a little variance of the resolution, I generated further images
with the resolution 218 nm and 242 nm and determined the number of dots as before,
Figure 6.15. Already by eye one can see that the uncertainty of the power of resolution
makes a comparison of simulation and experiment diﬃcult. It is impossible to distin-
guish between the scenario of monomers and dimers. A T-Test shows that depending
on the assumed power of resolution, either the scenarios "monomers" or "dimers" are
more likely. Furthermore one could assume distributions of oligomerization including
monomers, dimers and higher oligomers.
Figure 6.15.: Discrimination between the scenarios by number of dots per 100µm2: The error
bar represent cell-to-cell variation on the experiment, for the simulations they
represent the variation due to randomness of input parameters.
Monomers Dimers Trimers Resolution
10−3 0.67 10−5 218nm
0.6 0.03 10−13 230nm
0.007 10−3 10−9 242nm
Table 6.1.: T-Test for the comparison of experimental data to in silico images in Figure 6.15.
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The comparison of simulation and experiment allows for one certain conclusion: A bio-
logical scenario where CD95 is systematically trimerized on the plasma membrane can be
excluded. To achieve images with this number of dots, a substantial part of the receptors
must present itself as monomers or dimers on the plasma membrane. This statement
could only be found through modeling of the microscopy characteristics, since the mere
numbers: 4300 dots and 20000 receptors would suggest a higher clustering, rather than
excluding sheer trimerization.
Furthermore simulation indicates that the power of resolution plays a key role for dis-
crimination between monomers and dimers at physiological receptor concentrations on
HeLa cells. To illuminate the oligomerization level more, I aimed for high resolution
microscopy techniques.
6.3. Stimulated Emission Depletion allows for Higher
Resolution of Clusters
STED imaging was performed in collaboration with Matthias Reuss
(Stefan Hell, Optical Nanoscopy in Bioquant)
The spinning disc imaging and analysis in chapter 6.1 have shown that in HeLa cells
CD95-receptors are not massively clustered on the plasma membrane at physiological
expression. Notably I used two methods to estimate the amount of oligomerization.
One method was to determine the distribution of the dot intensities. By calibrating the
intensity scale using cells with known amounts of CD95-mGFP, I estimated the number
of receptors per dot. This number is lognormally distributed with a peak between one
and two receptors. However one dot does not necessarily correspond to only one receptor
oligomer, but might comprise more than one. Therefore the distribution of oligomers
might be shifted to even smaller numbers of receptors per cluster, indicating that a big
part of receptors presents itself in the range of monomers or dimers, chapter 6.1.4.
The other method was to simulate the random nature of oligomer distribution and the
microscopy features, particularly the resolution, assuming three possible biological sce-
narios, monomeric, dimeric or trimeric receptor. The simulations for a constitutive trimer
could not explain the high number of dots that were observed in the experiment indi-
cating that an eminent part of the receptors is monomeric or dimeric at the plasma
membrane.
Both of these complementing analysis methods, the calibration of the intensity scale and
the simulation of the random receptor distribution, speak for a large fraction of oligomers
lower than trimers.
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On the other hand the simulation illustrated the fact that one limiting aspect of these
experiments was the resolution. Therefore I performed the high resolution technique
stimulated emission depletion microscopy (STED) on the receptor in collaboration with
Matthias Reuss from the group of Stefan Hell: optical nanoscopy.
6.3.1. STED Imaging of CD95
To shed more light into the question of oligomerization level, the receptor was imaged
with the high resolution technique stimulated emission depletion (STED) in collaboration
with Matthias Reuss (Optical Nanoscopy, Stefan Hell) and then analyzed analogously to
before, chapter 6.1.1.
To image the receptor with STED the same staining procedure as for spinning disc imag-
ing, chapter 6.1, and flow cytometry, chapter 4.1.2, was used making a direct comparison
to these experiments possible. However the fluorescent dye had to be optimized to the
laser line of the instrument.
We tested anti-mouse antibodies with fluorescent dyes ATTO-647N and ATTO-635 both
suited in terms of laser wavelength of the stimulating and the depleting laser. The
ATTO-647N antibody proved to be brighter (higher signal to noise ratio) and since it is
less lipophilic exhibited less unspecific signal in the control (data not shown). Therefore
staining was performed as before using anti mouse ATTO-647N antibody (H+L).
Figure 6.16.: A pre-scan at low resolution serves as an orientation for the positioning under the
nucleus. The same settings are used for focussing on the lower plasma membrane.
Scale bar 5 µm.
The laser power of the depleting laser is orders of magnitude higher than the exciting
laser and these high energies lead to a relatively high bleaching. For this particular sam-
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ple bleaching allows only for one high resolution image to be taken and not stacks of
cells.
As shown before the lower plasma membrane under the cell nucleus is a good representa-
tion of the whole cell membrane regarding receptor distribution. Therefore low resolution
pre-scan was used to choose ROIs that lye directly beneath the nucleus and for focussing
on the lower plasma membrane, Figure 6.16. Then one high resolution image was ac-
quired at the predefined location, Figure 6.17.
Figure 6.17.: High resolution microscopy of CD95 receptor: HeLa were immunostained for CD95
with ms APO-1-3 and α-ms ATTO-647N antibody. The lower plasma membrane
beneath the nucleus was imaged with stimulated emission depletion microscopy.
Left: confocal resolution. Right: same position at STED resolution. ROIs mark
receptors, that could not be resolved at confocal resolution, but could be resolved
at STED resolution. Scale bar 5µm.
Figure 6.17 demonstrates that stimulated emission depletion allows for the resolving of
dots that were merged into one at confocal resolution.
Having established the protocol for sample preparation and imaging, we imaged the lower
plasma membrane of 20 randomly chosen cells for a comparison to Spinning Disc imaging
and analysis of oligomerization levels as described before.
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6.4. The Simulation of the Characteristics of STED Images
The simulation of STED microscopy is mainly analogous to the simulation of Spinning
Disc images. The input parameters have to be adapted to the diﬀerent images, as later
described. However two characteristic features need to be added for STED microscopy
simulation that are intrinsically diﬀerent from a physical point of view to those of the
confocal images, namely STED has a diﬀerent very characteristic point spread function
and due to low photon count per pixel the shot noise has to be considered as an addi-
tional feature for the simulation.
For the STED microscopy cell were stained with an antibody fused to fluorophor ATTO
647N instead of Alexa488 that was used for the spinning disc microscopy. To account
for this the antibody was attached alone to glass, the fluorescent dots measured and
segmented and the fluorescence distribution of the antibody was determined, analogous
to the measurement of the Alexa488 antibody fluorescence, chapter 6.2. Furthermore the
values for detector noise and background were determined on ROIs in the experimental
STED images that contained only background and no signal.
Figure 6.18.: The point spread function of the in simulated images corresponds to the experi-
mental images. The characteristic basement around the peak of the STED point
spread function was simulated with a gaussian of width 240 nm.
One of the additional features implemented for STED simulation is the shape of the point
spread function (PSF). As described in the introduction, chapter 2.2, the PSF for STED
diﬀers from the confocal not only in the width to account for the higher resolution but
also in the shape of the function, since it is not a gaussian peak but has an additional
characteristic basement around the center of the peak. This basement can be interpreted
as a ’local background’ that disturbs image analysis and therefore needs to be included
in the simulations. In the simulation the basement was implemented as an additional
gaussian curve with a much larger width of 240 nm and lower amplitude than the central
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peak of the point spread function, giving a good approximation to the experimentally
measured PSF, Figure 6.18.
(a) STED image (b) Simulation
Figure 6.19.: To achieve a higher comparability of the in silico images with experimental data
the shot noise was included in the simulation. (a) Experimental image with clearly
visible shot noise. (b) Simulation left without and right with shot noise. Scale bar
200 nm.
The second STED feature that was implemented additionally is the shot noise. The shot
noise diﬀers fundamentally from other kinds of noise in the fact that it is not a constant
random distribution but diﬀers as a function of the signal. In the simulations of confocal
imaging the shot noise was disregarded since it can be neglected against other sources
of noise that were implemented. In STED imaging however, due to the high resolution
and thus small pixel size, integration times per pixel become smaller, leading to a lower
number of photons per pixel than at confocal resolution, e.g. typical number of photons
per pixel in a peak are between 20 and 30, while background ranges between 0 and 1.
Therefore the shot noise is quite high and being the square root of photon counts
Nshot =
￿
number of photons
is not a constant distribution for all the pixels, as in confocal microscopy, but varies highly.
In the simulation the shot noise was implemented as a gaussian distribution of width one
multiplied by the square root of the signal of the pixel. Figure 6.19 demonstrates the
eﬀect of including shot noise in the simulations to achieve a good approximation to the
experimental image.
With the additional features of STED point spread function and the shot noise the sim-
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ulation is well adapted to approximate STED images. Again I used the simulation to
generate in silico images of the three biological scenarios, the receptor being monomeric,
dimeric or trimeric and compared these to the experimental images using as criterium
the number of dots estimated by image segmentation of the dots.
6.4.1. CD95 on HeLa Cells is either Dimeric or a Mix of Oligomers with a
Mean of Two Receptors per Cluster
To determine the oligomerization status of the receptor I generated in silico images of
monomeric, dimeric or trimeric receptors, Figure 6.20, in order to compare these to the
experimental data, Figure 6.22.
(a) In silico monomers (b) In silico dimers (c) In silico trimers
Figure 6.20.: In silico images of the three diﬀerent biological scenarios. To discriminate between
the three diﬀerent models, the receptor being monomeric, dimeric of trimeric,
in silico images were generated using the simulation workflow from chapter 6.2
including the additional STED-specific features of the point spread function and
the shot noise. In silico images were compared to the experimental images by
dot quantification using the dot segmentation tool in an analogous way to chapter
6.2.2. Scale bar 1µm.
To compare experimental and in silico images I used the criterium the number of dots
determined by the image analysis tool, analogously to the comparison at confocal res-
olution, chapter 6.2.2. Also the images analysis tool had to be adapted to the special
properties of the STED images. Due to the very small intensity values, resulting from
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the small pixel size in STED imaging, image analysis appeared to be even more sensitive
to the analysis parameters, than Spinning Disc images.
Therefore Bjoern Bachmann, in the context of an internship under my supervison, im-
plemented an image analysis tool determine best analysis parameters, by comparing the
STED images and confocal images of the same ROI. When imaging receptors at the
lower plasma membrane the signal of STED images is about a third of the photon count
of confocal images. Therefore dot recognition, i.e. the separation of the signal from
the noise is more presice on confocal images, while STED images provide a higher dot
resolution, i.e. the separation of two dots. The image analysis tool was established to
combine these two benefits, namely to use the information from the confocal images, to
exclude segmentation parameters that results in many wrongly segmented dots in STED
images.
The workflow was as described in the following. STED images were segmented with vary-
ing parameters for dots with the image analysis tool provided by Stefan Woerz, chapter
3.8. The results of these segmentations were used to generate artificial images at con-
focal resolution. In order to chose reasonable parameters for image segmentation these
artificial confocal images were compared to the experimental confocal images of the same
ROI and those parameters where chosen, that provided best accordance between artifi-
cial and experimental confocal images. The best parameters, see chapter 3.8 influence
of parameters, appeared to be a smoothing factor of 1.6, a threshold factor of 0.7 and a
fitting ROI of 6, as applied to the experimental image in Figure 6.22.
The validity of this image analysis was proven to be high by comparison to manual anal-
ysis, Figure 6.21. Error bars represent the cell to cell variation, estimated as a standard
deviation.
Figure 6.21.: Validity test for automated image analysis: the number of dots estimated by the
automated dot segmentation corresponds to the number of dots estimated by man-
ual analysis within the standard deviation.
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With this, we established a tool for image analysis that was used to analyse the STED
images. HeLa cells were immunostained for CD95 and the dotty pattern of the receptor
at the lower plasma membrane was imaged with STED. The mean number of dots per
100 µm2 was estimated to 333 ± 43, cell to cell variation.
(a) STED image (b) Image Analysis
Figure 6.22.: High resolution microscopy of CD95 receptor: HeLa were immunostained for CD95
with ms APO-1-3 and α-ms ATTO-647N antibody. The lower plasma membrane
beneath the nucleus was imaged with stimulated emission depletion microscopy.
Images were analysis with the image analysis tool described above using same
parameters as for the analysis of the in silico images. Scale bar 1 µm.
To test, which models scenario is in best accordance with the experiment, both experi-
mental and in silico images were segmented and dot number compared, Figure 6.23. The
error bar represents the cell to cell variation for the experimental images, respectively
the variation due to the random nature of receptor distribution in the in silico images.
Just as for the spinning disc images in chapter 6.2.2 the resolution of the experimental
images can only be determined to a certain accuracy, (71±3) nm. Therefore simulation
were performed at the diﬀerent resolutions within the error of the measured resolution.
The comparison to simulations of the biological scenarios shows a correspondence to the
the scenario of receptor dimers. This however does not take into account the very likely
possibility of a mix of oligomers that on average appears as a dimeric receptor. The
T-test , table 6.2, confirms the scenario of constitutive receptor monomers as well as of
constitutive receptor trimers can be excluded.
108
6. CD95-Clustering at Physiological Expression Levels
Figure 6.23.: The three in silico models are compared to the experimental images using the
number of dots per 100µm2 as discrimination criterium. For the experiment the
error bar represent the cell to cell variation, for the in silico images error bars
represent the variation due to randomness of receptor distribution. The models
of exclusively trimeric and of exclusively monomeric receptor can be excluded, see
also T-test in table 6.2. The experiment corresponds to the scenario of receptor
dimers whereupon a mix of oligomers is a likely model for receptor distribution on
HeLa.
The resolution does not play a significant role compared to the variation of dots numbers
due to randomness in the simulations.
Monomers Dimers Trimers Resolution
0.06 0.72 10−5 67nm
10−4 0.65 10−6 72nm
10−4 0.41 10−5 74nm
Table 6.2.: T-Test for the comparison of experimental data to in silico images in Figure 6.23.
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The high resolution STED-analysis of endogenous receptor clustering on HeLa cells
shows, that the CD95 distribution on the plasma membrane corresponds best to a sce-
nario of dimeric receptor. The scenarios of receptors being exclusively trimeric or exclu-
sively monomeric can be excluded. However it is reasonable to assume that receptors
are present at the plasma membrane in a distribution of diﬀerent oligomerization levels,
as already shown via calibration of the intensity axis with Spinning Disc data in chapter
6.1.4. The mode of the distribution however is at the oligomerization level of dimers.
6.4.2. CD95 is Monomeric in Knockdown Conditions
In the previous chapters, 6.1 and 6.3, I studied the oligomerization level of CD95 on
the plasma membrane at physiological expression levels. It was shown, that the recep-
tor is not a constitutive trimer but an eminent amount of the receptors is monomic or
dimeric at the plasma membrane. Furthermore the intensity of the dots that are observed
with spinning disc imaging follow a lognormal distribution, according to calibration in
chapter 6.1.4, with a peak between one and two receptor intensities. This speaks for
a model where receptor oligomerization follows an equilibrium that shifts to higher or
lower oligomer sizes according to receptor concentration.
Figure 6.24.: The three in silico models are compared to the experimental images in knockdown
conditions as before, Figure 6.23. The images of CD95 in knockdown conditions
correspond to the scenario of a monomeric receptor.
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To test the dependency of receptor oligomerization on the receptor concentration at the
plasma membrane, I performed STED imaging at low receptor concentrations using the
CD95 knockdown cell line. The low receptor concentration allows for an even better
resolution of single receptors so that images show well separated dots.
As in the previous chapter, the oligomerization level is studied by a comparison of the
experimental images with simulation generated images of the three biological scenarios,
monomic, dimeric or trimeric receptor. The STED in silico images were generated using
the same workflow as in the previous chapter only adapting the receptor amount to that
of the CD95 knockdown cells, 3000 receptors per cell. The number of dots was estimated
using the image analysis tool as in the previous chapter for experimental and in silico
images, Figure 6.24. The error bars represent the cell to cell variation for the experiment
and for the simulation the variation due to the random nature of the receptor distribution.
In knockdown conditions i.e. at very low receptor concentrations the CD95 receptor dis-
tribution corresponds to the scenario of a monomer. This is in agreement with a model
assuming that the receptor is present at the plasma membrane as a mix of oligomers
dependent on the receptor concentration and when receptor levels are pushed to low
concentrations the oligomers fall apart into monomers.
Contrary to what has been often presumed in literature, I could show via microscopy,
detailed image analysis, dot quantification and simulation of microscopy features as well
as random nature of spacial distribution, that CD95 at physiological levels on the plasma
membrane is not constitutively trimeric. Instead there has to be a significant amount of
monomeric or dimeric receptor at the plasma membrane.
High resolution microscopy was used to distinguish between monomeric or oligomeric
receptors. The comparison to simulations showed, that the receptor in HeLa cells is not
mainly monomeric, but a high amount of pre assembly of the receptor could be observed.
This confirms studies, that show receptor pre assembly, and identified a domain, the
PLAD, that is responsible for oligomerization.
However when receptor concentration becomes very low, receptors fall apart into monomers,
showing the concentration dependence of the binding strength of the PLAD domain.
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7.1. The CD95 Oligomerization after Induction
CD95 is one of the death receptors and plays an eminent role in apoptosis signaling. Its
main function in the organism is in the development of the immune system [12]. There
are a number of diseases related to the malfunctioning of this particular receptor [7].
There have been numerous studies on the importance of CD95 oligomerization and clus-
tering in apoptosis signaling. Biochemical experiments have shown a formation of SDS-
stable aggregates containing CD95 after induction of the receptor [36], [38], [35]. With
the fusion of receptors to fluorescent protein, the formation of signaling protein oligomer-
ization transduction structures (SPOTS) could be observed by microscopy [65], [37].
In Jurkat cells microscopy revealed a recruitment of most receptors to one domain at the
cell surface, a process named capping [48], [22].
In this work, I studied the cluster formation in the type II cell line HeLa, which were
induced with ILZ-sCD95L instead of the less physiological antibodies. Other experiments
in the laboratory, by Clarissa Liesche, have shown that the ILZ-sCD95L is trimeric, like
the sCD95L, but has a stronger aﬃnity than the latter. The transiently expressed CD95-
GFP was imaged with confocal microscopy at the lower plasma membrane. Within few
minutes of induction it was possible to observe the formation of dots. These were intact
structures, that stayed intact over time and diﬀused on the plasma membrane. High
quality images allowed for a precise image analysis, making it possible to quantify dots
and follow their formation in time. In order to relate to the observations and oligomer-
ization in other studies, I quantified the number of dots and number of molecules per
cluster. By relating to receptor concentrations measured via flow cytometry it was possi-
ble to calibrate the fluorescence intensity and estimate the number of molecules per dot.
The dots are sized following a lognormal distribution with the peak of the distribution
at receptor numbers less than 10.
I also characterized aggregation of the receptor by measuring their diﬀusion coeﬃcients.
When molecules aggregate, the radius of the diﬀusing particles increases, therefore they
diﬀuse slower than non aggregated molecules. Compared to the image analysis of dot
formation that is limited by detection, this dynamics measurement is more robust, be-
cause it measures receptor populations, but can also be more sensitive, as it is likely to
detect small clusters that may not be seen by normal imaging.
Although a decrease in diﬀusion coeﬃcient correlates with clustering, it is not possible
to quantitatively correlate this decrease with the number of molecules per cluster. When
lacking structural data about the receptor, as in the case of CD95, one can not pre-
cisely estimate the eﬀective radius of the oligomers, since arrangement of the receptors
in the oligomer might be diﬀering according to receptor type. There are diﬀerent models
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for receptor diﬀusion in the plasma membrane, that consider various diﬀusion hindering
mechanisms. While some receptors follow a Stokes-like diﬀusion model [76], [77] others
obey to the Saﬀman Delbrück model [75]. Therefore diﬀusion coeﬃcient measurements
can be highly sensitive for clustering, as in the case of dimerization measurement of
EGF receptors [105]. There again no change in diﬀusion coeﬃcient does not allow any
conclusions on presence or absence of clustering. Furthermore diﬀusion coeﬃcients are
measured on receptor populations and it is not possible to infer on the size distribution
of the oligomers.
The features of high robustness and possible high sensitivity for small oligomers make
dynamics measurement a good complement for the image analysis of dot formation, that
yields quantitative distribution data.
I utilized dynamics measurements to investigate the clustering of CD95-GFP upon in-
duction. Automated imaging allowed for a precise measurement of diﬀusion coeﬃcient
changes. After induction with ILZ-sCD95L, a massive slowdown of the receptor was ob-
served, form (0.158 ± 0.05) µm2/s to 0.04 µm2/s confirming the receptor clustering that
was measured by dot formation analysis.
In this study, I used two diﬀerent methods to observe CD95 receptor clustering in the
type II cell line HeLa upon induction with ILZ-sCD95L. This clustering likely corre-
sponds to the aggregate formation observed in type I cell lines as SDS-stable aggregates
and SPOTS formation with microscopy. Contrary to other studies, I measured cluster-
ing on whole, living cells at a single cell level. Both methods, the dot formation analysis
and the dynamics measurement comprehend a quantification of either the dot size or
the diﬀusion coeﬃcient and these values can be measured as a function of time. These
values provide a useful criterium to compare receptor clustering at diﬀerent conditions
and furthermore to compare the time scale at which clustering occurs. Thus using these
criteria I studied the various proposed clustering mechanisms of CD95 by measuring dif-
ferent receptor mutants.
7.2. The Lipid Rafts can be excluded as Oligomerization
Mechanism
Various mechanisms have been proposed to be involved in the aggregate formation of
CD95 after induction, notable the clustering by the ligand itself, lipid raft relocalization
and related actin association of receptors after induction [46], [47], [42], [21], [22] and
clustering by the death domain of the receptor [61], [63], [62].
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The relocalization of receptors into the lipid rafts is a confinement of the receptor to a
cell compartment that possibly leads to high local concentrations, making it one plausi-
ble mechanism for CD95 clustering eﬃcient caspase 8 activation and signal transduction.
Biochemical evidence shows the importance of lipid rafts for aggregate formation, for the
association to the cytoskeleton, receptor internalization and for apoptosis signaling [36].
The palmitoylation site at cysteine 199 constitutes a mechanistic evidence for lipid raft
participation as it is responsible for relocating of the receptor to lipid rafts [42] and is
essential for the formation of SDS-stable aggregates and cell death [38]. Inhibition of this
palmitoylation blocked aggregate formation and reduces caspase 8 activation. Evidence
for this derives from biochemical experiments using whole cell lysates and fractionations
and receptors were not observated on the plasma membrane. Most studies were per-
formed on type I cells, inducing with agonistic antibodies.
To test whether the formation of dots in type II cell line HeLa is palmitoylation depen-
dent, I studied a mutant C199V, where the palmitoylation site is mutated into a valine
that can not be palmitoylated in living cells. Microscopically, the same dots form. Image
analysis shows that their size was similar to that of the dots formed by the wild type
receptor. The dynamics measurement of the C199V mutant showed the same decrease
in the diﬀusion coeﬃcient as the wild type receptor, indicating that the aggregation
of receptors in HeLa is not dependent on the palmitoylation or lipid raft association.
Moreover further experiments in our laboratory, by Joël Beaudouin, showed the same
aggregation and diﬀusion coeﬃcient decrease when lipid rafts were destroyed by choles-
terol depletion with methyl β cyclodextrin.
Therefore the dots in HeLa cells do not follow the same formation mechanism as those
which were shown for the SDS-stable aggregates in type I cells. Dot formation and
receptor aggregation after induction in HeLa are independent of lipid raft association
and palmitoylation.
7.3. The Death Domains can be excluded as
Oligomerization Mechanism
Another mechanism involved in clustering is the self-association of the death domains of
the receptor. NMR studies on the death domain of CD95 and the complex formation
with the FADD death domain suggest that death domains themselves can lead to aggre-
gation. Under acidic conditions a four to four structure could be found, where an opening
of CD95 death domain structure exposes a binding site for FADD with promoting re-
ceptor clustering, so that the complex functions as a mechanistic switch [62]. However a
more recent study using more basic conditions found an asymmetric oligomeric structure
composed of five to seven CD95-death domains and five FADD death domain [63]. How-
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ever NMR studies of domains of purified proteins at high concentrations do not represent
the situation of full-length proteins in the plasma membrane of a living cell. Therefore,
this clustering mechanism does not necessarily reflect an active mechanism in living cells.
Moreover studies on Jurkat cells, using receptor mutants lacking the death domain, have
shown that an intact death domain is indispensible for the formation of SPOTS visible
with microscopy [37].
To test the contribution of the death domains in type II HeLa cells I studied a CD95
mutant in which the death domain was deleted. The mutant clustered at the plasma
membrane after induction with the ligand at the same speed and size as observed for the
wild type receptor. Diﬀusion coeﬃcient measurements by FRAP confirmed this finding:
the mutant showed the same slowdown after induction as the wild receptors.
Therefore we conclude that the mechanism for dot formation and receptor aggregation
in HeLa cells does not involve lipid rafts, nor is the clustering caused by death domain
aggregation or FADD association. The clustering mechanism, that was observed at high
receptor concentrations is likely only caused by the ligand.
7.4. The Oligomerization is Concentration Dependent
Most studies on CD95 clustering were performed in one cellular context, without testing
the eﬀect of concentrations especially the ones of the receptor.
In this study I calibrated of fluorescence on the microscope to quantify numbers of re-
ceptors inside the formed aggregates. With this I could show, that aggregate formation
is concentration dependent. Higher concentrations lead to higher aggregates, while at
lower receptor concentrations smaller dots are formed. Furthermore I measured receptor
oligomerization after induction at physiological expression levels (data not shown), but
could not observe a further clustering after induction, indicating that at these relatively
low concentrations further clustering by induction is below the detection limit. These
data at overexpression and observations at physiological expressions show the impor-
tance of initial receptor concentrations on the plasma membrane for the clustering after
induction.
The role of receptor concentrations was also tested in CD95 knockdown clones, where
flow cytometry measurements revealed that cell death percentage after induction is pro-
portional to the CD95 concentration on the cells, chapter 3.1. Generally I could observe
in the laboratory that CD95-overexpressing cells die faster than the same cells with phys-
iological CD95 expression levels. Both observations show that the function of CD95 is
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highly correlated to its concentration on the plasma membrane.
To complement the many studies at high receptor concentrations - most of them involve
biochemical evidence or NMR studies of the purified receptor - I characterized the re-
ceptor distribution on the plasma membrane of living cells at physiological expression
levels.
7.5. Oligomerization on the Plasma Membrane at
Physiological Expression Levels
Most evidence for the oligomerization levels of CD95 is drawn by analogy to the other
members of the TNF receptor superfamily [60], [54].
There are diﬀerent evidences speaking for a pre-ligand assembly of the receptor. Domi-
nant interference of some CD95 mutants causing the disease called ALPS (autoimmune
lymphoproliferative syndrome) of the receptors can only be explained by a pre-ligand
assembly of the receptor. A special domain at the N-terminal part of the TNF receptors,
the so called PLAD, has been shown to be responsible for this assembly and has been
confirmed for CD95 on ALPS mutants. CD95 has not yet been crystallized as a whole
protein. Therefore structural data are taken from NMR data of single domains or in
analogy to TNF structures. CD95 ligand is most likely trimeric. Therefore the receptor
is often assumed to be trimeric [3]. However direct evidence is still lacking. In fact there
is evidence that TNFR-1, CD27 and CD40 (other receptors of the TNF-receptor family)
are dimeric through intermolecular disulfide bonds [54], [58] .
I characterized the receptor distribution at physiological expression levels on the cell
plasma membrane with confocal microscopy. For this protocol for staining and imaging
of the receptor was established. With spinning disc confocal microscopy it was possi-
ble to image the endogenous CD95 receptor in three dimensions and resolve the spacial
distribution as a dotty pattern on the plasma membrane. To study the distribution of
dot intensities and relate to receptor amount, I established an image processing pipe
line: dots are segmented by the dot segmentation program and dot intensity histograms
are generated, that show a lognormal distribution of dot intensities. Analysis of these
intensity histograms provided a precise estimate of the number of dots per cell and re-
vealed that dot intensity distribution is lognormal. By calibrating the intensity it was
shown that the dots at the peak of the distribution contain around between one and two
receptors per dot.
This characterization of the intensity distributions is not enough to conclude on the
oligomerization of the receptor as they can be randomly near to each other, so that due
to limited resolution they appear as one dot. A simple calculation tells us, that equally
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distributed receptors would a distance of about 0.3 µm, which approximates the limit
of resolution. Therefore I performed a simulation to regard the randomness of location
and the microscopy features. Notably the resolution, but also the noise, background
and fluorescence distribution of the antibodies were modeled following the parameters of
the images in order to generate in simulated images of the receptors. These simulations
showed that in fact, the limit of resolution and the random nature of receptor distri-
bution and staining play an eminent role, when analyzing the dotty pattern of receptor
distribution.
The simulation was used to generate in silico images of three scenarios: namely a
monomeric, dimeric or a trimeric receptor, with all the characteristics of the experimen-
tal images. A comparison of in silico and experimental images showed that the scenario
of the receptor being trimeric can be excluded. A separation between monomers and
dimers was not possible, and this limitation could directly be referred to the limitations
in resolution.
Therefore considering the intensity distribution and image simulation I found that on
HeLa cells at endogenous expression levels a large fraction of the receptor must be mono-
or dimeric. This is in contrast to the typical assumption in literature of a constitutively
trimeric receptor.
Furthermore the simulations demonstrated the central importance of resolution for micro-
scopic measurements of receptor clustering. Therefore in a collaboration with Matthias
Reuss from the group of Stefan Hell, optical nanoscopy, high resolution microscopy with
stimulated emission depletion (STED) was performed. The receptors were imaged in two
dimensions at the lower plasma membrane of the cell beneath the nucleus at a resolution
of 70 nm. A comparison could show that high resolution allows for the separation of
spots, that were merged by diﬀraction in confocal images.
I performed analogous simulations considering the diﬀerent features such as form of point
spread function and shot noise. The high resolution allowed for a discrimination between
the possibilities, distinctly excluding a scenario of exclusively monomeric receptors on
the plasma membrane. The experiments were consistent with the simulation of dimers,
however one can not exclude the plausible possibility of a mix of populations. However
the experiment is consistent with a pre-assembly that was experimentally observed at
high concentrations and with the role of the PLAD-domain to oligomerize the receptors
in the absence of the ligand.
When exploring knockdown conditions, meaning even lower receptor concentrations, sim-
ulations of receptor monomers are in good agreement with the data in the receptor falls
into monomers. This indicates, that at lower concentration levels, the receptor falls into
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monomers, showing that the mechanism of pre-ligand assembly is concentration depen-
dent.
Combining the experimental results I propose the second of the four models introduced
in chapter 1.2.2 for receptor clustering and related apoptosis sensitivity. The recep-
tor clustering mechanism is determined by a pre-ligand assembly of the receptor and a
crosslinking by the ligand. Simulations allow to exclude the proposed model of a consti-
tutively trimeric receptor. Instead oligomerization is a dynamic process and the receptor
is present as a mixed distribution of diﬀerent oligomerization levels that depend on the
initial receptor concentration. This distribution is shifted towards monomers or dimers
for physiological concentrations and can experimentally be shifted towards monomers by
a knockdown of the receptor. Moreover also the death-inducing function of the receptor
is correlated with the initial receptor concentration.
Upon induction the ligand crosslinks the receptor. This crosslinking alone is a strong
mechanism that can lead to massive formation of detectable dots with seven and more
receptors per dot. It highly depends on the initial receptor concentration. Additional
experiments in our laboratory indicate that one other critical feature for the cell death
inducing function it is the aﬃnity of the ligand to the receptors.
Therefore I propose a model, where the sensitivity of a cell to CD95 induced apoptosis
correlated to the receptor clustering that is defined by two critical features: the initial
receptor concentration and the ligand aﬃnity.
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A.1. Estimation of the Diﬀusion Coeﬃcient from the
Bleaching Profile
To determine the diﬀusion coeﬃcient from recovery of a bleached stripe, one has to relate
the spacial intensity pattern of a stripe in the images of every time point to diﬀusion
equation ((A.1)) in time and space:
∂I(x, t)
∂t
= D
∂2I(x, t)
∂2x
(A.1)
One approach solution is to assume a gaussian profile for the stripe where intensity scales
with 1/
√
2πσ:
I(x, t) =
c0
σ
√
2π
exp
￿−x2
2σ2
￿
(A.2)
The tryout assumption is:
σ2 = 2Dt (A.3)
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πDt
exp
￿−x2
4Dt
￿
(A.4)
Take the derivative of this equation:
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(A.7)
Put these partial derivatives into the diﬀusion equation ((A.1)) to test, whether our
assumptions hold true. ￿
x2
4Dt2
￿
+
￿−1
2t
￿
=
￿−2x
4Dt
￿2
− 2
4Dt
(A.8)
Our Ansatz (A.4) solves the diﬀusion equation, therefor we can determine the diﬀusion
coeﬃcient D as the slope in (A.3)
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Glossary
ALPS autoimmune lymphoproliferative syndrome: desease related to CD95. 13
Apoptosis one mode of programmed cell death. 8
caspases a group of proteases responsible for the execution of apoptosis. 10
CD95L the respective ligand of the CD95 receptor, there are two main forms studied in
the lab: the soluble form sCD95L and an artificially trimerized form ILZ-sCD95L.
14
Confocal Microscopy a techniques for three dimensional imaging. 26
Diﬀusion a process by which molecules move randomly e.g. due to temperature (Brow-
nian motion). 37
Expression Levels proteins expression in cells is regulated tightly, protein expression can
vary naturally however especially the transient or stable expression of artificially
constructed proteins can vary highly from the endogenous levels. 55
FADD Fas-Associated protein with Death Domain, FADD is directly recruited by CD95
(Fas) and connects it to the downstream caspases. 10
Flow cytometry a technique to measure full cell (or particle) fluorescent intensities with
high statistics. 49
FRAP fluorescence recovery after photobleaching is a technique to measure the diﬀusion
of fluorescent molecules by bleaching the molecules in one region and observing
fluorescence recovery in that region. 39
GFP green fluorescent protein. 26
HeLa immortal cervical cancer cell line of type I. 16
Immunostaining is a technique to stain proteins in cell by attaching fluorescent anti-
bodies. 48
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Glossary
Lipid rafts cell plasma membrane domaines that are enriched in cholesterine, glycolipids
and sphingolipids. 17
Lognormal distribution is a mathematical function the plotted on a logorithmic scale
appears as a gaussion. Many proteins are distributed according to a lognormal
distribution.. 66
Nyquist Sampling follow the rule of Nyquist for the choice of pixel sizes in microscopy.
33
Palmitoylation posttranslational modification, attachment of fatty acids, e.g. palmitic
acid to an amino acid in a protein, often related to the regulation of the localization
in the membrane. 16
PLAD pre-ligand-assembly domain, a domain of the CD95 receptor related to its assem-
bly before Induction. 13
PSF the point spread function describes the appearance of a point source in imaging.
33
Resolution is a quantity to describe whether two sources of light can be discriminated
from each other. 32
Signal the fluorescent signal in microscopy is proportional to the number of fluorescent
molecule and can therefore be used for quantification of clustering. 30
Spinning Disc is a microscopy technique that allows a much faster scanning by using
1000 pinholes instead of one at a time. 30
STED stimulated emission microscopy is a high resolution technique, that increases
resolution of molecule by depleting fluorescent molecules int the surrounding area.
34
Type I and Type II cells cells can be classified according to the apoptosis pathway they
perform: extrinic type I and intrinsic type II. 15
z-vad a caspase inhibitor that blocks apoptosis. 14
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